PUBLICATIONS

A select list of published articles and abstracts authored by Genetics & IVF Institute professional staff.

1984   1985   1986   1987   1988   1989  
1990   1991   1992   1993   1994   1995  
1996   1997   1998   1999   2000   2001
2002   2003   2004  2005   2006  

 

1984

1. Marrs, R.P. and Schulman, J.D., “Human In Vitro Fertilization and Embryo Transfer,” Gynecology and Obstetrics, Vol. 5, 1984.
2. Schulman, J.D., “Metabolic Diseases and In Utero Therapy,” in M.R. Harrison, M.S. Golbus, and R.A. Filly (eds.), The Unborn Patient: Prenatal Diagnosis and Treatment, Grune and Stratton, New York, 1984, p. 183.
3. Schulman, J.D. “Conception Following Embryo Catheter Passage,” (letter) Lancet, Vol. 2, 1984, p. 524.
4. Striffler, N., Jones, S.L. and Bronheim, S., Human Cost of Chronic Illness, Proceedings of a workshop, Georgetown University Child Development Center, Washington, DC, 1984.
5. Weiss, J.O. and Jones, S.L., Education in Genetics II: Nurses and Social Workers, Proceedings of a conference, Georgetown University, Washington, DC, 1984.

 

1985

1. Dorfmann, A., Jones, S.L., Joyce, B., Hanser, J., Patton, L., Clancy, C., Bui, M. and Schulman, J.D., “150 Consecutive Chorionic Villus Samplings in a Specialized Outpatient Clinical and Laboratory Facility,” American Journal of Human Genetics, Vol. 37, 1985, p. A215.
2. Evans, M.I., Kolodny, E., Schulman, J.D., et al, “Lysosomal Enzymes in Chorionic Villi, Cultured Amniocytes, and Cultured Skin Fibroblasts,” Soc Gyn Investigation, Phoenix, AZ, 1985.
3. Fletcher, J.C. and Schulman, J.D., “Fetal Research: The State of the Question,” Hastings Ctr Rep, Vol.15, 1985, p. 6.
4. Schulman, J.D., “Transvaginal Oocyte Recovery for IVF,” American Fertility Society, Chicago, IL, September 1985.
5. Schulman, J.D., Dorfmann, A., Jones, S. and Joyce, B., “Transvaginal Ultrasound-guided Oocyte Retrieval for IVF in an Integrated, Outpatient IVF/Genetics Unit,” 4th World Congress on In Vitro Fertilization and Embryo Transfer, Melbourne, Australia, November 1985.
6. Schulman, J.D., Dorfmann, A. and Evans, M.I., “Genetic Aspects of In Vitro Fertilization,” Ann NY Acad Sci, Vol. 442, 1985, p. 466.
7. Schulman, J.D., “Prenatal Treatment of Biochemical Disorders,” in Golbus, M.S. (ed.) Seminars in Perinatology, 1985.
8. Schulman, J.D., “Laparoscopy for In Vitro Fertilization: End of an Era,” Fertil Steril Vol. 44, 1985, p. 713.
9. Schulman, J.D., “Safety of Chorionic Villus Sampling,” Lancet Vol. I, 1985, p. 1164(letter).
10. Schulman, J.D., Dorfmann, A., Jones, S., Joyce, B. and Hanser, J., “Outpatient In Vitro Fertilization Using Transvaginal Oocyte Retrieval,” New Engl J Med, Vol. 312, 1985, p. 1639.
11. Williams, J.K., Jones, S. and Wright, L., “Genetic Concepts in Graduate Nursing Education,” Amer J Human Genet, Vol. 37, 1985, p. A138.

 

1986

1. Bartsocas, C.S., Bernstein, J., Orloff, S., Chandra, R. and Schulman, J.D., “A Familial Syndrome of Growth Retardation, Severe Fanconi-type Renal Disease and Glomerular Changes--a New Entity?,” Int J Pediatr Nephrol, Vol. 7, 1986, p. 101.
2. Black, S.H., Hejtmancik, J.F. and Pollack, M.F., “Congenital Adrenal Hyperplasia (CAM) and Malformations in a Child with a De Novo Deletion on Chromosome 6,” Amer J Human Genet, Vol. 39, 1986, p. A90.
3. Bustillo, M., Dorfmann, A., Bender, A., Jones, S.L., Rothschild, G. and Schulman, J.D., “Clinical and Cytogenetic Findings in IVF Abortuses and Continuing Pregnancies,” Soc Gyn Investigation, Toronto, Canada, March 1986.
4. Bustillo, M., Schwimer, W., Jones, S.L., Rothschild, G., Dorfmann, A., Bender, S. and Schulman, J.D., “Pregnancies Achieved with IVF Under Suboptimal Cycle Conditions,” Soc Gyn Investigation, Toronto, Canada, March 1986.
5. Black, S.H., Pelias, M.Z., Miller, J.B., Blitzer, M.G. and Shapira, E., “Maroteaux-Lamy Syndrome in a Large Consanguineous Kindred: Biochemical and Immunological Studies,” Amer J Med Genet, Vol. 25, 1986, pp. 273-279.
6. Dorfmann, A., Jones, S.L., Joyce, B., Patton, L.A. and Pitt, C., “Transvaginal Ultrasound Guided Oocyte Retrieval as the Method of Choice for Human In Vitro Fertilization,” Soc Gyn Investigation, Toronto, Canada, March 1986.
7. Dorfmann, A., Patton, L., Clancy, C., Bui, M.Q., Pitt, C., Joyce, B., Leonard, S., Sigler, M.B., Jones, S. and Schulman, J.D., “Improved CVS Cytogenetic Analysis: Experience in over 400 Cases,” 7th International Congress of Human Genetics, Berlin (West), 1986.
8. Dorfmann, A., Patton, L., Bender, S., Jones, S.L., Joyce, B. and Schulman, J.D., “Mosaicism and Tetraploidy in Chorionic Trophoblast,” Amer J Human Genet, Vol. 39, 1986, p. A253.
9. Evans, M.I. and Schulman, J.D., “Biochemical Fetal Therapy,” Clin Obstet Gynecol, Vol. 29, 1986, p. 523.
10. Evans, M.I. and Schulman, J.D., “Prenatal Diagnosis: Invasive Techniques and Alpha Fetoprotein Screening,” in Aver, G.B. (ed.), Neonatology: Pathophysiology and Management of the Newborn, Harper Lippincott, Philadelphia, 1986.
11. Evans, M.I. and Schulman, J.D., “Biochemical Fetal Therapy,” in Schulman, J.D. (ed.), Clinical Obstetrics and Gynecology, 1986.
12. Evans, M.I., Moore, C., Kolodny, E.H., Casassa, M., Schulman, J.D., et al., “Lysosomal Enzymes in Chorionic Villi, Cultured Amniocytes, and Cultured Skin Fibroblasts,” Clin Chim Acta, Vol. 157, 1986, p.109.
13. Gahl, W., Reed, G., Thoene, J., Schulman, J., Rizzo, W., Jonas, A., Denman, D., Schlesselman, J. and Schneider, J., “Long-term Oral Cysteamine Therapy Helps Maintain Renal Glomerular Function and Improves Growth in Nephropathic Cystinosis,” The Society for Pediatric Research, 1986.
14. Gates, A.J. and Black, S.H., “Isolated Congenital Hyposplenia (ICH) in Two Generations of Non-consanguineous Family,” Amer J Human Genet Vol. 39, 1986, p. A61.
15. Jones, S.L., Dorfmann, A., Patton, L., Pitt, C., Clancy, C., Bui, M.Q., Joyce, B., Leonard, S., Sigler, M.B. and Schulman, J.D., “Non-viable Pregnancy in Patients Anticipating Chorionic Villus Sampling,” 7th International Congress of Human Genetics, Berlin (West), 1986.
16. Jones, S.L., Dorfmann, A., Patton, L.A., Pitt, C., Joyce, B. and Schulman, J.D., “Importance of the Premature LH Surge in IVF Cycles with Low Dose Pergonal Follicle Stimulation,” Soc Gyn Investigation, Toronto, Canada, March 1986.
17. Jones, S.L. and Weiss, J.O., Incorporation of Genetics into Clinical Practice: A Manual for a Continuing Education Course, Georgetown University, Washington, DC, 1986.
18. Jones, S.L., “Casefinding,” in Felton, G. (ed.), Nursing Practice in Clinical Genetics: Prospects for the 21st Century, University of Iowa Press, 1986.
19. Jones, S., Dorfmann, A., Patton, L., Pitt, C., Joyce, B., Sigler, M.E., Fleming, G., Rosen, L. and Schulman, J.D., “Non-viable Pregnancy in Patients Anticipating Chorionic Villus Sampling,” Amer J Human Genet Vol. 39, 1986, p. A257.
20. Kolker, A., Schulman, J.D. and Jones, S.L., “CVS: Promises and Problems,” American Sociological Association, 1986.
21. Pollack, M.S., Carrol, M.C., Black, S., Leech, S.H., Callaway, C., Harris, S., Ward, P.A., Morris, J. and Hejtmancik, J.F., “Congenital 21-hydroxylase Deficiency as a New Mutation: Detection During Prenatal Diagnosis by HLA-typing and DNA Analysis,” American Society of Histocompatibility and Immunogenetics, 1986.
22. Schulman J.D., Bustillo M., Dorfmann A.D., Jones S.L., Patton L.A. and Pitt C., “Exclusive Use of Ultrasound Guided Oocyte Retrieval for IVF in an Integrated, Outpatient IVF/genetics Unit,” Poster Presentation, 42nd Annual Meeting of American Fertility Society, Toronto, Canada, Sept 1986.
23. Schulman, J.D. (ed.), “Fetal Therapy” (volume), Clinical Obstetrics and Gynecologv, 1986.
24. Schulman, J.D., “Delayed Expulsion of Transfer Fluid After IVF/ET,” Lancet Vol. I, 1986, p. 44.
25. *Sigler, M.E., Colyer, C., Hani, V., Dorfmann, A., Jones, S.L. and Schulman, J.D., “Maternal Serum Alpha-fetoprotein (MSAFP) Screening after Chorionic Villus Sampling,” Amer J Human Genet Vol. 39, 1986, p. A265.

 

1987

1. Bender, S., Howard-Peebles, P.N. and Black, S.H., “Phenotypic Abnormalities in Partial Lq Trisomy Associated with a Maternal Lq Inversion,” Amer J Human Genet, Vol. 41, 1987, p. A46.
2. Black, S.H., Dorfmann, A., Colyer, C., Sigler, M., Bender, S., Robinson, P., Roberts, J. and Schulman, J.D., “Amniocentesis After Transcervical Chorionic Villus Sampling (CVS): Mosaicism and Elevated Maternal Serum Alpha-fetoprotein (MSAFP) Concentrations,” Amer J Human Genet, Vol. 41, 1987, p. A267.
3. Bustillo, M., Bender, S., Dorfmann, A., Jones, S.L., Rothschild, E. and Schulman, J.D., “Outcome of IVF Cycles in Relation to Serum Estradiol at Time of HCG,” American Fertility Society, 1987.
4. Bustillo, M., Dorfmann, A.D., Bender, S., Jones, S.L., Rothschild, G. and Schulman, J.D., “Experience with a Declining High Dose HMG Regimen for Ovulation Induction in IVF,” 5th World Congress on IVF and Embryo Transfer, 1987.
5. Butler, J.D., and multiple authors, including Schulman, J.D., “Glutathione Metabolism in Normal and Cystinotic Fibroblasts,” Exp Cell Res, Vol. 172, 1987, p. 158.
6. Dorfmann, A.D., Bender, S., Robinson, P., Fugger, E.F., Bustillo, M. and Schulman, J.D., “Effects of Reduced Oxygen Concentration on In Vitro Fertilization and Cleavage of Human Oocytes,” Fertil Steril, 43rd Meeting Program Supplement, 1987, p. 46.
7. Evans, M.I. and Schulman, J.D., “Prenatal Diagnosis: Invasive Techniques and Alpha- fetoprotein Screening,” in Avery, G.B. (ed.), Neonatologv: Pathophysiologv and Management of the Newbor, 3rd ed., J.B. Lippincott and Co., Philadelphia, 1987.
8. Gahl, W.A., Reed, G.F., Thoene, J.G., Schulman, J.D., Rizzo, M.D., Jones, A.J., Denman, D.W., Schlesselman, J.J., Corden, B.J. and Schneider, J.A., “Cysteamine Therapy for Children with Nephropathic Cystinosis,” New Engl J Med Vol. 316, 1987, p. 971.
9. Hossaini, A.A., Demers, D., Odelberg, S., Polesky, H. and Schanfield, M., “Paternity Testing when Putative Father is not Available,” 5th Annual Medical Laboratory Immunology Symposium, Williamsburg, Virginia, May 1987, p. 5.
10. Jones, S.L., Rothschild, G. and Labbe-Anhut, D., “Transvaginal Ultrasound-guided Oocyte Retrieval,” 2nd Annual Conference for IVF Nurse Coordinators, Norfolk, VA, 1987.
11. Robertson, J.A. and Schulman, J.D., “Pregnancy and Prenatal Harm to Offspring: the Case of Mothers with PKU,” Hastings Ctr Rep, Vol. 17, 1987, p. 23.
12. Schneider, J.A. and Schulman, J.D., “Cystinosis and the Fanconi Syndrome,” in Andreoli, T.E., Hoffman, J.F., Fanestil, D.D., and Schultz, S.G. (eds.), Clinical Disorders of Membrane Transport Processes, Plenum Medical Book Publishers, New York, 1987.
13. Schulman, J.D., Dorfmann, A.D., Jones, S.L., Pitt, C.C., Joyce, B. and Patton, L.A., “Outpatient In Vitro Fertilization using Transvaginal Ultrasound Guided Oocyte Retrieval,” Obstet Gynecol, Vol. 69, 1987, p. 665.
14. Schulman, J.D., “Cystinosis,” in Milunsky, A. (ed.), Genetic Disorders of the Fetus, 2nd ed., Plenum Publishing Corporation, New York, New York, 1987.
15. Schulman, J.D., “Safety of Chorionic Villus Sampling,” Lancet, Vol. I, 1987, p. 1085.
16. Sigler, M.E., Colyer, C.R., Rossiter, J.P., Dorfmann, A.D., Jones, S.L. and Schulman, J.D., “Maternal Serum Alpha-fetoprotein Screening after Chorionic Villus Sampling,” Obstet. Gynecol., Vol. 70, 1987, p. 875.

1988

1. Black, S.H., Chambers, S., Blackwell, L., Roberts, J.A. and Schulman, J.D., “Cystic Nuchal Abnormalities Identified by Sonography in the First Trimester in Two Fetuses with Trisomy 18,” 4th International Conference on Chorionic Villus Sampling and Early Prenatal Diagnosis, Athens, Greece, May 1988.
2. Black, S.H., Chambers, S., Soenksen, D., Roberts, J. and Schulman, J.D., “Cystic Nuchal Abnormalities Identified by Sonography in the First Trimester in Three Fetuses with Trisomy 18,” Amer J Human Genet, Vol. 43, 1988, p. A226.
3. Black, S.H. and Schulman, J.D., “Letter to the Editor: Prenatal Sampling and Bicorunate Uterus,” Prenat Diag, Vol. 8, 1988, pp. 476-477.
4. Bustillo, M., Dorfmann, A., Munabi, A. and Schulman, J.D., “Cumulative Experience and Prospective Randomization: Clomiphene and Gonadotropins (CC-HMO) Versus Gonadotropins (HMO) Alone for Ovulation Induction in IVF,” Soc Gyn Investigation, Abstract #144, 35th Annual Meeting, Baltimore, MD, March 1988.
5. Bustillo, M., Munabi, A.K. and Schulman, J.D., “Pregnancy after Nonsurgical Ultrasound-guided Gamete Intrafallopian Transfer,” New Engl J Med, Vol. 319, 1988, p. 313.
6. Dorfmann, A.D., Black, S.H., Roberts, J., Robinson, P., Bender, S., Patton, L. and Schulman, J.D., “Stromal Mosaicism using an In Situ Method of Culture for Chromosomal Analysis of Chorionic Villi,” Amer J Human Genet, Vol. 43, 1988, p. A231.
7. Dorfmann, A., Black, S.H., Roberts, J., Bender, S. and Schulman, J.D., “Stromal Mosaicism using an In Situ Method of Culture for Chromosomal Analysis of Chorionic Villi: Trisomy 12 Mosaicism not Confirmed at Amniocentesis,” 4th International Conference on Chorionic Villus Sampling and Early Prenatal Diagnosis, Athens, Greece, May 1988.
8. Farrell, J.W., Morgan, K.S. and Black, S., “Lensectomy in an Infant with Cri-du-chat Syndrome and Cataracts,” Pediatr Opth Strab, Vol. 25, 1998, p. 131-134.
9. Fugger, E.F., Bustillo, M., Munabi, A.K., Rothchild, G. and Schulman, J.D., “Factors Affecting Embryonic Development and Pregnancy from Cryopreserved Human Pronucleate (PN) Zygotes,” 44th Annual Meeting of American Fertility Society, Oral presentation #056, October 1988.
10. Fugger, E.F., Bustillo, M., Dorfmann, A.D. and Schulman, J.D., “The Effect of Human Amniotic Fluid on In Vitro Development of Mouse Embryos,” Society for the Study of Reproduction, 1988.
11. Fugger, E.F., Bustillo, M., Dorfmann, A.D., Bender, S.D. and Schulman, J.D., “Embryonic Development and Pregnancy from Fresh and Cryopreserved Sibling Pronucleate (PN) Human Zygotes,” Soc Gyn Investigation, 35th Annual Meeting, Abstract #166, Baltimore, MD, March 1988.
12. Fugger, E.F., Bustillo, M., Katz, L., Dorfmann, A., Bender, S.D. and Schulman, J.D., “Embryonic Development and Pregnancy from Fresh and Cryopreserved Sibling Pronucleate Human Zygotes,” Fertil Steril, Vol. 50, 1988, pp. 273-278.
13. Green, J.E., Dorfmann, A.D., Jones, S.L., Bender, S., Patton, L. and Schulman, J.D., “Chorionic Villus Sampling: Experience with an Initial 940 Cases,” Obstet Gynecol, Vol. 71, 1988, pp. 208-212.
14. Jones, S.L., “Decision Making in Clinical Genetics: Ethical Implications for Perinatal Nursing Practice,” J Perinatal Neonatal Nurs, Vol. 1, 1988, pp. 11-23.
15. Kalousek, D.K., Howard-Peebles, P.N., Dorfmann, A.D., Black, S.H. and Schulman, J.D., “Confined Trophoblastic Mosaicism for Trisomy 13 with a Normal Newborn,” Amer J Human Genet, Vol. 43, 1988, p. A237.
16. Munabi, A., King, D., Bustillo, M., Dorfmann, A.D. and Schulman, J.D., “Effect of Serum Testosterone on Pregnancy in Human In Vitro Fertilization,” Endocrine Society, Abstract #739, 1988.
17. Odelberg, S.J., Demers, D.B., Westin, E.H. and Hossaini, A.A., “Establishing Paternity using Minisatellite DNA Probes when the Putative Father is Unavailable for Testing,” J Forensic Sci, Vol. 33, 1988, pp. 921-928.
18. Schulman, J.D., Black, S.H., Soenksen, D., Jones, S. and Dorfmann, A.D., “Transvaginal Chorionic Villus Sampling: an Ultrasound-guided Needle Aspiration Method,” Amer J Human Genet, Vol. 43, 1988, p. A249.
19. Schulman, J.D., Black, S.H., Soenksen, D., Jones, S. and Dorfmann, A., “Transvaginal Chorionic Villus Sampling: an Ultrasound-guided Needle Aspiration Method,” 4th International Conference on Chorionic Villus Sampling and Early Prenatal Diagnosis, Athens, Greece, May 1988.
20. Schulman, J.D., Black, S.H., Soenksen, D., Jones, S.L. and Dorfmann, A.D., “Transvaginal Chorionic Sampling During the First Trimester of Pregnancy,” New Engl J Med, Vol. 319, 1988, p. 1612.
21. Schulman, J.D., “Medical In-utero Therapy,” in Vogel, F. and Sperling, K. (eds.), Human Genetics: Proceedings of the 7th International Congress of Human Genetics, Springer-Verlag, Berlin, 1988.
22. Schulman, J.D. and Evans, M.I, “Biochemical Fetal Therapy,” in Harrison, M.R., Filly, R. and Golbus, M.S. (eds.), The Unborn Patient, 2nd ed., Grune and Stratton, New York, 1988.

1989

1. Ballabio, A., Carrozzo, R., Bick, D., Andrh, G. and Fraccaro, M., “Deletion Map of the Xp22.3-pter Region Obtained by the Study of Patients with Contiguous Gene Syndromes. Human Gene Mapping 10,” Cytogenet Cell Genet, Vol. 51, 1989, p. 957.
2. Ballabio, A., Bardoni, B., Carrozzo, R., Andria, G., Bick, D.P., Campbell, L., Hamel, B., Ferguson-Smith, M.A., Gimelli, G., Fraccaro, M., Maraschio, P., Zuffardi, O., Guioli, S. and Camerino, G., “Contiguous Gene Syndromes Due to Deletions in the Distal Short Arm of the Human X Chromosome,” Proc Natl Acad Sci, Vol. 86, 1989, pp. 10001-10005.
3. Bender, S., Robinson, P., Dorfmann, A., Bustillo, M., Munabi, A. and Schulman, J.D., “Effect of Randomly Selected Tape Color Coding for Culture Dish Labeling in IVF,” 6th World Congress IVF and Alternate Assisted Reproduction, 1989.
4. Bender, S.D., Dorfmann, A.D., Schulman, J.D. and Bustillo, M., “Tetraploidy and Aneuploidy after Observation of Diploid Fertilization In Vitro,” Fertil Steril, Vol. 52, 1989, p. 1070.
5. Bick, D., Snead, M., Yen, P.H., McGill, J., Schorderet, D., Hejtnnancik, J.F., Ballabio, A., Campbell, L. L., Moore, C., Curry, C.J., Lau, E.C. and Shapiro, L., “Mapping Chondrodysplasia Punctata, Ichthyosis, Kallmann Syndrome and DNA Markers in Male Patients with Xp Chromosome Deletions,” Cytogenet Cell Genet, Vol. 51, 1989, p. 962.
6. Bick, D.P., Schwanzel-Fukuda, M., Pfaff, D.W., Schorderet, D.F., Price, P.A., Campbell, L., Huff, R.W. and Moore, C.M., “Prenatal Diagnosis and Investigation of a Fetus with Chondrodysplasia Punctata, Ichthyosis and Kallmann Syndrome due to an Xp Deletion: Evidence for a Neuronal Migration Fefect in Kallmann Syndrome,” Amer J Human Genet, Vol. 45, 1989, p. A252.
7. Bick, D.P., Curry, C.J.R., McGill, J., Schorderet, D.F., Bux, R.C. and Moore, C.M., “A Male Infant with Ichthyosis, Kallmann Syndrome, Chondrodysplasia Punctata and an Xp Chromosome Deletion,” Amer J Med Genet, Vol. 33, 1989, pp. 100-107.
8. Black, S.H., Howard-Peebles, P.N., Kalousek, D.K., Dorfmann, A. and Schulman, J.D., “Complex Mosaicism on Chorionic Sampling Confirmed Postnatally,” Amer J Human Genet, Vol. 45, 1989, p. A252.
9. Bustillo, M., Bhattarai, S., Munabi, A.K., Bender, S., Dorfmann, A. and Schulman, J.D., “Life Table Analysis of Pregnancy Attainment in an IVF Program Exclusively Utilizing Ultrasound-guided Oocyte Retrieval,” 6th World Congress IVF and Alternate Assisted Reproduction, 1989.
10. Bustillo, M., Munabi, A.K., Bender, S., Dorfmann, A. and Schulman, J.D., “Transcervical Ultrasound-guided Intrafallopian Placement of Gametes, Zygotes, and Embryos,” 6th World Congress IVF and Alternate Assisted Reproduction, 1989.
11. Bustillo, M., Bender, S., Fugger, E., Dorfmann, A.D., Munabi, A. and Schulman, J.D., “Initial Experience with Partial Zone Dissection in Cases Anticipated to have Poor Fertilization Rates in Human IVF,” American Fertility Society (Fertil Steril, 45th Meeting Program Supplement), 1989, p. S41.
12. Costakos, D., Black, S.H., Dorfmann, A., Howard-Peebles, P.N., Robinson, P. and Schulman, J.D., “Chorionic Villus Sampling Mosaicism: Counseling Issues,” National Society of Genetic Counselors Proceedings, 1989.
13. Dorfmann, A.D., Bender, S.D., Robinson, P., Fugger, E.F., Bustillo, M., Reed, G. and Schulman, J.D., “Cell-free Human Amniotic Fluid as Culture Medium for Mouse and Human Embryos,” Fertil Steril, Vol. 51, 1989, p. 671-674.
14. Evans, M.I., Dixler, A.O., Fletcher, J.C. and Schulman, J.D. (eds.), Fetal Diagnosis and Therapy: Science. Ethics and the Law, J.B. Lippincott Company, Philadelphia, PA, 1989.
15. Evans, M.I., Quigg, M.H., Koppitch, F.C. III and Schulman, J.D., “First Trimester Prenatal Diagnosis,” in Evans, M.I., Dixler, A.O., Fletcher, J.C. and Schulman, J.D. (eds.), Fetal Diagnosis and Therapy: Science. Ethics and the Law, J.B. Lippincott Company, Philadelphia, PA, 1989, p. 17-36.
16. Evans, M.I. and Schulman, J.D., “Medical Fetal Therapy,” in Evans, M.I., Dixler, A.O., Fletcher, J.C. and Schulman, J.D. (eds.), Fetal Diagnosis and Therapy: Science. Ethics and the Law, J.B. Lippincott Company, Philadelphia, PA, 1989, p. 403-412.
17. Evans, M.I. and Schulman, J.D., “Developing Issues in Reproduction. Scientific Issues,” in Evans, M.I., Dixler, A.O., Fletcher, J.C. and Schulman, J.D. (eds.), Fetal Diagnosis and Therapy: Science. Ethics and the Law, J.B. Lippincott Company, Philadelphia, PA, 1989, p. 34.
18. Fugger, E.F., Katz, L.P. and Schulman, J.D., “Effect of Partial Zone Dissection and Reduced Sperm Count on Murine In Vitro Fertilization and Cleavage Rates,” Fertil Steril, American Fertility Society 45th Meeting Program Supplemen), 1989, p. S108.
19. Fugger, E.F., Katz, L.P., Bustillo, M., Bender, S.D., Dorfmann, A.D. and Schulman, J.D., “Pregnancy from Cryopreserved Human Zygotes and Embryos Transferred During Clomiphene Citrate Stimulated and Natural Replacement Cycles,” Fertil Steril, American Fertility Society 45th Meeting Program Supplement, 1989, p. S110.
20. Fugger, E.F., “Clinical Status of Human Embryo Cryopreservation in the United States of America,” Fertil Steril, Vol. 52, 1989, pp. 986-990.
21. Howard-Peebles, P.N., Black, S.H., Bustillo, M., Maddalena, A., Steane, E.A. and Litsenberger, B., “Trisomy 8 in a Male/Female Chimera,” Amer J Human Genet, Vol. 45, 1989, p. A78.
22. Howard-Peebles, P.N., Black, S.H., Bustillo, M., Maddalena, A., Steane, E.A. and Litsenberger, B., “Trisomy 8 in a Chimera,” 27th Annual American Cytogenetics Conference, Houston, TX, March 1989.
23. Jones, S.L., “The Genetic Evaluation: Implications for Donor Screening,” 2nd Annual Meeting of the International Society of Nurses in Genetics, Workshop, Baltimore, MD, 1989.
24. Jones, S.L., “The Scope of Reproductive Options,” 2nd Annual Meeting of the International Society of Nurses in Genetics, Baltimore, Maryland, 1989.
25. Mattison, D.R., Ewing, L.L., Generoso, W.M., Paulsen, C.A., Robaire, B., Sherins, R., et al., “Biologic Markers of Human Male Reproductive Health and Physiologic Damage,” in Grossblatt, N. and Paulson, L.R. (eds.), Biologic Markers in Reproductive Toxicology, National Academy Press, Washington, DC, 1989, pp. 83-105.
26. Munabi, A.K., King, D., Bender, S., Bustillo, M., Dorfmann, A. and Schulman, J.D., “LH Surge Shortly before HCG is Associated with Reduced Pregnancy Rate in IVF,” 6th World Congress IVF and Alternate Assisted Reproduction, 1989.
27. Pergament, E., Wapner, R.J., Jackson, L.G., Schulman, J.D., Ginsberg, N.A., Verlinsky, Y. and Black, S.H., “First Trimester Genetic Diagnosis in Twin Pregnancies: Safety and Accuracy,” 6th International Congress on Twin Studies, August, 1989.
28. Ryan, S.G., Bick, D.P., Mackley, R.W. and Naylor, S.L., “Hereditary Startle Disease: Clinical Features and Response to Clonazepam in a Large Pedigree Amenable to Linkage Analysis,” Amer J Human Genet, Vol. 45, 1989, p. A61.
29. Schulman, J.D. and Bustillo, M., “Clinical and Research Aspects of In Vitro Fertilization,” in Evans, M.I., Dixler, A.O., Fletcher, J.C. and Schulman, J.D. (eds.), Fetal Diagnosis and Therapy: Science. Ethics and the Law, J.B. Lippincott Company, Philadelphia, PA, 1989, pp. 349-355.
30. Schulman, J.D., “Cystinosis,” Prog Clin Biol Res, Vol. 305, 1989, p. 137.
31. Schwanzel-Fukuda, M., Bick, D. and Pfaff, D.W., “Luteinizing Hormone-Releasing Hormone (LHRH) Cells do not Migrate Normally in Kallmann's Syndrome (Hypogonadotropic Hypogonadism with Anosmia),” Soc Neurosci Abs, 1989.
32. Schwanzel-Fukuda, M., Bick, D.P. and Pfaff, D.W., “Luteinizing Hormone-Releasing Hormone (LHRH)-expressing Cells do not Migrate Normally in an Inherited Hypogonadal (Kallmann) Syndrome,” Mol Brain Research, Vol. 6, 1989, pp. 311-326.
33. Rizzo, W.B., Danman, A.A., Craft, D.A., Black, S.H., Henderson, A.N., Africk, D., Charvas-Carballo, E., Holingren, G. and Jagell, S., “Sjogren-Larsson Syndrome: Inherited Defect in the Fatty Alcohol Cycle,” J Pediat, Vol. 2, 1989, pp. 228-234.

1990

1. Bick, D.P., Maddalena, A., Black, S.H., Costakos, D., Cummings, E., Jones, S.L., Headrick, E.G. and Schulman, J.D., “Pilot Study of Prenatal Screening for the DeltaF508 Cystic Fibrosis (CF) Mutation in an Unselected Population,” Amer J Human Genet, Vol. 47, 1990, p. A209.
2. Bick, D., Maddalena, A., Black, S.H., Headrick, E.G., Cummings, E., Jones, S.L., Costakos, D., Becker, R. and Schulman, J.D., “Prenatal Screening for Delta-F508 Cystic Fibrosis Mutation in a Population not Selected for Cystic Fibrosis,” Lancet, Vol. 336, 1990, pp. 1324-1325.
3. Black, S.H., “Prenatal Development End Clinical Genetics,” in Ziai, M. (ed.), Pediatrics, 4th ed., Little, Brown & Co., Boston, MA, 1990.
4. Bustillo, M., Armstrong, A.Y., Munabi, A. and Schulman, J.D., “The Effect of Maternal Age on Estradiol and Progesterone Levels in Conception and Non Conception Cycles Following IVF,” American Fertility Society, October 1990.
5. Bustillo, M., Thorsell, L., Yap, S., Dorfmann, A.D., Fugger, E.F. and Schulman, J.D., “Endometrial Receptivity after Transfer of Frozen-thawed Human Embryos: Randomized Trial of Controlled Versus Natural Cycles,” Soc Gyn Investigation, 1990.
6. Bustillo, M. and Schulman, J.D., “Transcervical Ultrasound-guided Intrafallopian Placement of Gametes, Zygotes, and Embryos,” J In Vitro Fert Embryo Transf, Vol. 6, 1990, p. 321.
7. Calvo, L., Dennison, L., Banks, S., Goldstein, A., Fugger, E.F. and Sherins, R.J., “BSA in the Capacitation Medium is Superior to Fetal Cord Serum in Facilitating Follicular Fluid Induced Acrosome Reaction in Human Sperm,” Fertil Steril, American Fertility Society 46th meeting program supplement, 1990, p. S133.
8. Cheah, M.S.C., McDonald, S. and Bick, D., “Regulation of the Human for Proto-oncogene Expression During Fetal Liver Development,” The American Pediatric Society/The Society for Pediatric Research, 1990.
9. Costakos, D., Black, S.H., Dorfmann, A., Howard-Peebles, P.N., Robinson, P. and Schulman, J.D., “Chorionic Villus Sampling Mosaicism: Counseling Issues. Strategies in Genetic Counseling: Reproductive Genetics and New Technologies,” Birth Defects: Original Articles Series, Vol. 26, March of Dimes, Birth Defects Foundation, 1990, pp. 64-68.
10. Demers, D.B., Odelberg, S.J. and Fisher, L.McA., “Identification of a Factor IX Point Mutation Using SSCP Analysis and Direct Sequencing,” Nucleic Acids Res, Vol. 18, 1990, p. 5575.
11. Dennison, L.L., Calvo, L., Banks, A.G., Fugger, E.F. and Sherins, R.J., “The Ability of Capacitated Human Sperm to Undergo Follicular Fluid Stimulated Acrosome Reaction is Affected by Ionic Composition of the Medium Through Curvilinear Velocity at Early Stages of Capacitation Remains Unaltered,” American Society of Andrology, 1990.
12. Gahl, W.A., Schneider, J.A., Schulman, J.D., Thoene, J.G. and Reed, G.F., “Predicted Reciprocal Serum Creatinine at Age 10 Years as a Measure of Renal Function in Children with Nephropathic Cystinosis Treated with Oral Cysteamine,” Pediatr Nephrol, Vol. 4, 1990, p. 129.
13. Gentleman, S., Kaiser-Kupfer, M.I. and Sherins, R.J., “Biochemical Analysis of Axonemal Proteins in Men with Retinal Degeneration,” ARVO, Sarasota, FL, April 1990.
14. Jones, S.L., “The Role of Genetics in Reproductive Decision Making,” 4th National Conference for IVF Nurse Coordinators and Support Personnel, St. Petersburg, FL, 1990.
15. Jones, S.L., “The Genetic Evaluation: Implications for Donor Screening,” 4th National Conference for IVF Nurse Coordinators and Support Personnel, Workshop, St. Petersburg, FL, 1990.
16. Jones, S.L., “Prenatal Screening End Diagnosis: Cystic Fibrosis,” 3rd Annual Meeting of the International Society of Nurses in Genetics, Workshop, Cincinnati, OH, 1990.
17. Jones, S.L., “Principles of Genetics,” 23rd Annual Postgraduate Program, American Fertility Society, Washington, DC, 1990.
18. Kalousek, D.K., Howard-Peebles, P.N., Barrett, I.J., Black, S.H. and Schulman, J.D., “Confirmation of CVS Mosaicism in Term Placentas and its Associated High Incidence of Intrauterine Growth Retardation,” 5th International Congress on Early Fetal Diagnosis, Prague, Czechoslovakia, July 1990, p. 125.
19. Kalousek, D.K., Howard-Peebles, P.N., Barrett, I.J., Black, S.H., Schulman, J.D., Wilson, R.D., Costakos, D.M. and Dorfmann, A.D., “Confirmation of CVS Mosaicism in Term Placentas and Correlation with Pregnancy Outcome,” Amer J Human Gene, Vol. 47, 1990, p. A279.
20. Kalousek, D.K., Howard-Peebles, P.N., Barrett, I.J., Black, S.H., Schulman, J.D. and Wilson, R.D., “Confirmation of CVS Mosaicism in Term Placentas and its Association with High Frequency of Intrauterine Growth Retardation,” in Macek, M., Ferguson-Smith M.A. and Spala, M. (eds.), Early Fetal Diagnosis: Recent Progress and Public Health Impact, Karolinum-Charles University Press, Prague, 1990.
21. Maddalena, A., Bick, D.P., Fugger, E., Jones, S. and Schulman, J.D., “Screening of Sperm Donors for the Delta-F508 Cystic Fibrosis Mutation,” Amer J Human Genet, Vol. 47, 1990, p. A290.
22. Munabi, A., Armstrong, A.Y., Bustillo, M., Bender, S. and Schulman, J.D., “Effect of Maternal Age on Pregnancy Rate per Embryo,” American Fertility Society, October 1990.
23. Munabi, A.K., King, D., Bender, S., Bustillo, M., Dorfmann, A. and Schulman J.D., “Small Increases in Circulating Luteinizing Hormone (LH) Concentrations Shortly Before Human Chorionic Gonadotropin (hCG) are Associated with Reduced In Vitro Fertilization (IVF) Pregnancy Rate,” J In Vitro Fertil Embryo Transf, Vol. 7, 1990, pp. 310-313.
24. Schulman, J.D., “Treatment of the Embryo and the Fetus in the First Trimester: Current Status and Future Prospects,” Amer J. Med Genet, Vol. 35, 1990, p. 197.
25. Schulman, J.D., Maddalena, A., Black, S.H. and Bick, D.P., “Screening for Cystic Fibrosis Carriers,” Amer J Human Genet, Vol. 47, 1990, p. 740.
26. Schulman, J.D., “Prenatal Diagnosis of Rare Diseases,” Frontiers in Rare Disease Research, Proceedings from the symposium, National Institutes of Health, 1990.
27. Sherins, R.J., “Practical and Basic Science Insights in the Treatment of Males with Gonadotropin Deficiency,” in Ehlich, R.M. (ed.), Dialogues in Pediatric Urology, Vol. 13, 1990, pp. 6-8.
28. Sidransky, E., Black, S.H., Soenksen, D.M., Jones, S.J., Dorfmann, A.D. and Schulman, J.D., “Transvaginal Chorionic Villus Sampling,” Prenat Diagn, Vol. 10, 1990, p. 583.

1991

1. Bodurtha, J., Nance, W., Demers, D., Maddalena, A. and Schulman, J., “Detection of Incest with Polymorphic Markers,” 8th International Congress of Human Genetics, Washington, DC, October 1991, p. 489.
2. Bustillo, M., Thorsell, L., Yap, S., Dorfmann, A.D., Fugger, E.F. and Schulman, J.D., “Endometrial Receptivity after Transfer of Frozen-thawed Human Embryos: Randomized Trial of Controlled Versus Natural Cycles,” Soc Gyn Investigation, 1991.
3. Bustillo, M., Fugger, E.F. and Schulman, J.D., “New Reproductive Techniques,” New Engl J Med, Vol. 325, 1991, p. 1043.
4. Coulam, C.B., “Epidemiology of Recurrent Spontaneous Abortion,” Amer J Reprod Immunol, Vol. 25, 1991, pp. 23-27.
5. Coulam, C.B., Peters, A.J., Gentry, M., Gentry, W., Critser, E.S. and Critser, J.K., “Pregnancy Rates after Peritoneal Ovam-sperm Transfer,” Amer J Obstet Gynecol, Vol. 164, 1991, pp. 1447-1454.
6. Coulam, C.B. and Stern, J.J., “Immunology of Ovarian Failure,” Amer J Reprod Immunol, Vol. 25, 1991, pp. 169-174.
7. Dennison, L., Calvo, L., Banks, S., Dorfmann, A., Bustillo, M., Schulman, J. and Coulam, C.B., “Workshop A: Unification of Immunotherapy Protocols,” 10th Anniversary Meeting, American Society for the Immunology of Reproduction, Chicago, IL, June 1990. Amer J Reprod Immunol, Vol. 25, 1991, pp. 1-9, 1991.
8. Evans, M.I., Pinsky, W.W., Johnson, M.P. and Schulman, J.D., “Pharmacologic and Gene Therapy,” in Evans, M.I. (ed.), Reproductive Risks and Prenatal Diagnosis, Appleton & Lange, Norwalk, CT, 1991.
9. Fields, R.A., Schulman, J.D. and Fugger, E.F., “Survival and Development of Biopsied Frozen and Refrozen Murine Embryos,” World Congress on In Vitro Fertilization and Assisted Procreation, 1991.
10. Fisch, G.S., Shapiro, L.R., Simensen, R., Schwartz, C.E., Fryns, J.-P., Borghgraef, M., Curfs, L.M., Howard-Peebles, P.N., Arinami, T. and Mavrou, A., “Differences in Decline in IQ Among Fragile-X Males: Evidence for Genetic Heterogeneity?,” 8th International Congress of Human Genetics, Washington, DC, October 1991, p. 469.
11. Fisch, G.S., Arinami, T., Froster-Iskenius, U., Fryns, J.-P., Curfs, L.M., Borghgraef, M., Howard-Peebles, P.N., Schwartz, C.E., Simensen, R.J. and Shapiro, L.R., “The Relationship Between Age and IQ Among Fragile X Males: a Multicenter Study,” Amer J Med Genet, Vol. 38, 1991, pp. 481-487.
12. Fugger, E.F., Bustillo, M., Dorfmann, A.D. and Schulman, J.D., “Human Preimplantation Embryo Cryopreservation: Selected Aspects,” Human Reprod, Vol. 6, 1991, pp. 131-135.
13. Headrick, E.G., Shannon, L.L., Ives, M.S., Schulte, J. and Jones, S.L., “The Effect of Nursing Intervention on the Level of Uncertainty Rxperienced by Women Following IVF and Embryo Transfer,” 47th Annual Meeting of American Fertility Society, Orlando, FL, 1991.
14. Howard-Peebles, P.N., “Fragile X Screening vs Family Studies (Especially in Females): Laboratory Procedures/Guidelines,” Cytogenet Cell Genet, Vol. 56, 1991, p. 217.
15. Howard-Peebles, P.N., “Effects of EDTA on Growth and Fragile X Expression,” Amer J Med Genet, Vol. 38, 1991, p. 516.
16. Howard-Peebles, P.N., “Fragile X Testing of Family Members in the Clinical Cytogenetics Laboratory: Perimeters and Pitfalls,” 8th International Congress of Human Genetics, Washington, DC, October 1991, p. 290.
17. Howard-Peebles, P.N., “Letter to the Editor: Fragile X Expression: Use of a Double Induction System,” Amer J Med Genet, Vol. 38, 1991, pp. 445-446.
18. Jacky, P.B., Ahuja, Y.R., Anyane-Yeboa, K., Breg, W.R., Carpenter, N.J., Froster- Iskenius, U.G., Fryns, J.-P., Gustavson, K.-H., Hoegerman, S.F., Holmgren, G., Howard-Peebles, P.N., Jenkins, E.C., Krawczun, M.S., Neri, G., Pettigrew, A., Schaap, T., Schonberg, S.A., Shapiro, L.R., Spinner, N., Steinbach, P., Vianna-Morgante, A.M., Watson, M.S. and Wilmot, P.L., “Guidelines for the Preparation and Analysis of the Fragile X Chromosome in Lymphocytes,” Amer J Med Genet, Vol. 38, 1991, pp. 400-403.
19. Jenkins, E.C., Krawczun, M.S., Stark-Houck, S.L., Duncan, C.J., Kunaporn, S., Gu, H., Schwartz-Richstein, C., Howard-Peebles, P.N., Gross, A. and Brown, W.T., “Improved Prenatal Detection of Fra(X)(q27.3): Methods for Prevention of False Negatives in Chorionic Villus and Amniotic Fluid Cell Cultures,” , Vol. 38, 1991, pp. 447-452.
20. Jones, S.L., “The Role of Genetics in Reproduction,” 2nd International Conference of IVF Nurse Coordinators and Support Personnel, Workshop, Paris, France, 1991.
21. Kalousek, D.K., Howard-Peebles, P.N., Magenis, R.E., Barrett, I.J., Black, S.H., Schulman, J.D. and Wilson, R.D., “Confirmation of CVS Mosaicism in Term Placentas and High Frequency of Intrauterine Growth Retardation Association with Confined Placental Mosaicism,” Prenat Diagn, Vol. 11, 1991, pp. 743-750.
22. Ketterer, D.M., Jackson-Cook, C.K., Howard-Peebles, P.N., Casey, J., Heisler, K.L., Daugherty, E.A. and Giles, H.R., 8th International Congress of Human Genetics, Washington, DC, October 1991, p. 221.
23. King, D.A., Fallon, L., Dorfmann, A., Jones, S.L., McCorkle, R.D. and Schulman, J.D., “Amniocentesis after Elevated Maternal Serum Alpha Fetoprotein (AFP) Concentrations: Cytogenetic Considerations in Women Under Age 35,” 8th International Congress of Human Genetics, Washington, DC, October 6-11 1991, p. 221.
24. Maddalena, A., Bick, D.P., Black, S.H., Hansma, D.I., Cummings, E., Jones, S.L., Fallon, L., Headrick, E.G. and Schulman, J.D., “Prenatal Screening for Cystic Ffibrosis (CF) in United States Couples without a Previously Affected Child,” 8th International Congress of Human Genetics, Washington, DC, October 1991, p. 329.
25. Levinson G., Fields, R., Maddalena, A., Fugger, E.F., Harton, G.L. and Schulman, J.D., “Rapid Prenatal or Preimplantation Diagnosis of Cystic Fibrosis using Small Samples or Single Cells,” 5th Annual North American Cystic Fibrosis Conference, Dallas, TX, October 1991.
26. McCombs, J., Rouse, B., Lockhart, L. and Howard-Peebles, P., “Prenatal Identification of Fragile X and a Marker Chromosome,” 8th International Congress of Human Genetics, Washington, DC, October 6-11 1991, p. 303.
27. Park, C.Y., Bick, D.P. and Bustamante, S.A., “Disaccharidase Activity in the Human Fetal Intestine: Focus on Early Ontogeny,” Southern Society for Pediatric Research, 1991.
28. Plattner, R., Heerema, N.A., Patil, S.R., Howard-Peebles, P.N. and Palmer, C.G., “Characterization of Seven DA/DAPI-positive Bisatellited Marker Chromosomes by In Situ Hybridization,” Human Genet, Vol. 87, 1991, pp. 290-296.
29. Peters, A.J. and Coulam, C.B., “Hysterosalpingography with Color Doppler Ultrasonography,” Amer J Obstet Gynecol, Vol. 164, 1991, pp. 1530-1534.
30. Sherins, R., “Sperm Acrosome Reaction and Seminal Morphology Predict the Percent of Eggs Fertilized at IVF,” American Society of Andrology, Montreal, Canada, April 27-30 1991.
31. Sherins, R.J., “Diagnosis End Treatment of Human Male Infertility,” Annual Meeting of Society for Theriogenology, San Diego, CA, 1991, pp. 23-28.
32. Sherins, R.J., “Clinical Use and Misuse of Automated Semen Analysis,” New York Acad Sc, Vol. 637, 1991, pp. 424-435.
33. Stern, J.J., Peters, A.J. and Coulam, C.B., “Transcervical Tuboplasty Under Ultrasonographic Guidance: a Pilot Study,” Fertil Steril, Vol. 56, pp. 359-360.
34. Swaroop, A., Agarwal, N., Gruen, J.R., Bick, D.P. and Weissman, S.M., “Differential Expression of Novel Gs Signal Transduction Protein cDNA Species,” Nucleic Acids Res, Vol. 19, 1991, pp. 4725-4729.
35. Tezon, J., Calvo, L., Miranda, P., Dennison, L., Banks, S. and Sherins, R.J., “Fibronectin Localization over the Equatorial Segment is Related to the Ability of Capacitated Sperm to Acrosome React,” North American Testis Workshop, Montreal, Canada, April 24-27 1991.
36. Wasmoen, T.L., Coulam, C.B., Benirshke, K. and Gleich, G.J., “Association of Immunoreactive Eosinophil Major Basic Protein with Placental Septa and Cysts,” Amer J Obstet Gynecol, Vol. 165, 1991, pp. 416-420.
37. Wild, R.A., Hirisave, V., Podczaski, E.S., Coulam, C.B., Shivers, C.A. and Satyaswaroop, R.G., “Autoantibodies Associated with Endometriosis: Can their Detection Predict Presence of the Disease?,” Obstet Gynecol, Vol. 77, 1991, p. 927.
38. Williams, C.B., Blankenhorn, E.P., Byrd, K.E., Levinson, G. and Gutman, G.A., “Organization and Nucleotide Sequence of the Rat T Cell Receptor Beta-chain Complex,” I, Vol. 146, 1991, pp. 4406-4413.

1992

1. Bick, D.P., Schorderet, D.F., Price, P.A., Campbell, L., Huff, R.W., Shapiro, L.J. and Moore, C.M., “Prenatal Diagnosis and Investigation of a Fetus with Chondrodysplasia Punctata, Ichthyosis, and Kallmann Syndrome due to an Xp Deletion,” Prenat Diagn, Vol. 12, 1992, pp. 19-29.
2. Bick, D., Brunella, F., Sherins, R.J., Heye, B., Pike, L., Crawford, J., Maddalena, A., Incerti, B., Pragliola, A., Meitinger, T. and Ballabio, A., “Intragenic Deletion of the Kalig-1 Gene in Kallmann's Syndrome,” New Engl J Med, Vol. 326, 1992, pp. 1752-1755.
3. Bilas, R., Wilhelm, D., Schwinger, E., Chudley, A.E., Fryns, J.P., Howard-Peebles, P.N., Schinzel, A., Van Roy, B. and Webb, T., “Expression of the Fragile-X in the "Premutated"/"Non-imprinted" State,” Genet Counsel, Vol. 3, 1992, pp. 179-181.
4. Black, S.H., Maddalena, A., Bick, D.P., Levinson, G., Howard-Peebles, P.N. and Schulman, J.D., “Molecular Fragile X Screening in a Pregnant Population with Family Histories of Mental Retardation (MR) or Learning Disabilities (LD),” Amer J Human Genet, Vol. 51, 1992, p. A20.
5. Black, S.H., “The Genetics of Fragile X Syndrome,” in Schopmeyer, B.B. and Lowe, F (eds.), The Fragile X Child, Singular Publishing Group, Inc., San Diego, CA, 1992.
6. Calvo, L., Dennison, L., Banks, S., Dorfmann, A., Bustillo, M., Schulman, J. and Sherins, R., “Acrosome Reaction and Sperm Concentration in Semen Serve as the Best Two-parameter Model for Predicting Fertilization Success at IVF,” American Society of Andrology, Washington, DC, March 28-30 1992.
7. Chen, Z.W., Yamamoto, H., Watkins, D.I., Levinson, G. and Letvin, N.L., “Predominant use of a T-cell Receptor V Beta Gene Family in Simian Immunodeficiency Virus Gag-specific Cytotoxic T Lymphocytes in a Rhesus Monkey,” J Virol, Vol. 66, 1992, pp. 3913-3917.
8. Coulam, C.B., “Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy Loss,” Sandoz Pharmaceutical Corporation Meeting, Mar Del Plata, Argentina, October 30-November 1 1992.
9. Coulam, C.B., “Immunotherapy for Unexplained Infertility,” International Federation of Fertility Societies (IFFS), 14th World Congress, Caracas, Venezuela, November 22-27 1992.
10. Coulam, C.B., “Association between Infertility and Spontaneous Abortion,” Amer J Reprod Immunol, Vol. 77, 1992, pp. 128-129.
11. Coulam, C.B. and Stern, J.J., “Evaluation of Immunological Infertility,” Amer J Reprod Immunol, Vol. 27, 1992, pp. 130-135.
12. Coulam, C.B., “Immunologic Tests in the Evaluation of Reproductive Disorders: a Critical Review,” Amer J Obstet Gynecol, Vol. 167, 1992, pp. 1844-1851.
13. Coulam, C.B. and Coulam, C.H., “Update on Immunotherapy for Recurrent Pregnancy Loss,” Amer J Reprod Immunol, Vol. 27, 1992, pp. 124-127.
14. Dorfmann, A.D., Keyvanfar, K., Yap, S. and Schulman, J.D. “Fluorescence In Situ Hybridization (FISH) of Human Polypronucleate Preimplantation Embryos,” Amer J Human Gene, Vol. 51, 1992, p. A255.
15. Dorfmann, A.D., Perszyk, J., Robinson, P., Black, S.H. and Schulman, J.D., “Rare Non-mosaic Trisomies in Chorionic Villus Tissue not Confirmed at Amniocentesis,” Prenat Diagn, Vol. 1, 1992, pp. 899-902.
16. Fields, R.A., Fugger, E.F., Levinson, G. and Schulman, J.D., “Survival of Cryopreserved Biopsied Zone-free Murine Blastocysts,” 48th Annual Meeting of American Fertility Society, 1992.
17. Fisch, G.S., Shapiro, L.R., Simensen, R., Schwartz, C.E., Fryns, J.P., Borghgraef, M., Curfs, L.M., Howard-Peebles, P.N., Arinami, T. and Mavrou, A., “Longitudinal Changes in IQ among Fragile X Males: Clinical Evidence of More than One Mutation?,” Amer J Med Genet, Vol. 43, 1992, pp. 28-34.
18. Fugger, E.F., Hazelrigg, W.B., Kraynick, J., Maddalena, A., Pool, S.H., Stone, Jr., G. and Schulman, J.D., “Results of Genetic and Medical Evaluation of 3731 Semen Donor Applicants over a 4-1/2 Year Period,” 48th Annual Meeting of American Fertility Society, 1992.
19. Hejtmancik, J.F., Black, S.H., Harris, S., Ward, P.A., Callaway, C., Ledbetter, D., Morris, J., Leech, S.H. and Pollack, M.S., “Congenital 21-hydroxylase Deficiency as a New Deletion Mutation: Detection in a Proband during Subsequent Prenatal Diagnosis by HLA Typing and DNA Analysis,” Human Immunol, Vol. 35, 1992, pp. 246-252.
20. Howard-Peebles, P.N., “Prenatal Diagnosis of Fragile X: Experience in 3 Laboratories,” in Hagerman, R.J. and McKenzie, P. (eds.), 1992 International Fragile X Conference Proceedings, Spectra Publishing Co., Dillon, CO, 1992, pp. 345-348.
21. Howard-Peebles, P.N., “Letter to the Editor: the Effect of Dialyzed Sera on Fragile X Expression,” Amer J Med Genet, Vol. 43, 1992, p. 161.
22. Howard-Peebles, P.N. and Maddalena, A., “Recent Experience in Prenatal Diagnosis of Fragile X,” Amer J Med Genet, Vol. 43, 1992, pp. 162-166.
23. Howard-Peebles, P.N., Schneider, N.R. and Maddalena, A., “Fragile X Syndrome,” in Rosenberg, R.N., Prusiner, S.B., DiMauro, S., Barchi, R.L. and Runkel, L.M. (eds.), The Molecular and Genetic Basis of Neurological Disease, Butterworths, Stoneham, MA, 1992, pp.79-89.
24. Jackson, L.G., Zachary, J.M., Fowler, S.E., Desnick, R.J., Golbus, M.S., Ledbetter, D.H., Mahoney, M.J., Pergament, E., Simpson, J.L., Black, S.H., Wapner, R.J. and the U.S. National Institute of Child Health and Human Development Chorionic Villus Sampling and Amniocentesis Study Group, “A Randomized Comparison of Transcervical and Transabdominal Chorionic-villus Sampling,” New Engl J Med, Vol. 327, 1992, pp. 594-598.
25. Jones, S.L. and Headrick, E.G., “Integration of Clinical Fenetics into Assisted Reproductive Technologies: Implications for Nursing Practice,” NAACOG's Clinical Issues, Vol. 3, 1992, pp. 301-312.
26. Kalousek, D.K., Harrison, K.J., Barrett, I.J., Lomax, B.L., Kuchinka, B.D., Wilson, R.D. and Howard-Peebles, P.N., “Confirmation of Prenatally Diagnosed Chromosomal Aneuploidy using Fluorescence In Situ Hybridization,” Amer J Human Genet, Vol. 51, 1992, p. A259.
27. Langlois, S., Barrett, I., Yam, I., Wilson, R.D., Howard-Peebles, P.N., Johnson, M.P., Giorgiutti, E. and Kalousek, D.K., “Fetal Uniparental Disomy for Chromosome 16 in Pregnancies with Confined Placental Mosaicism,” Amer J Human Genet, Vol. 51, 1992, p. A18.
28. Ledbetter, D.H., Zachary, J.M., Simpson, J.L., Golbus, M.S., Pergament, E., Jackson, L., Mahoney, M.J., Desnick, R.J., Schulman, J.D., Copeland, K.L., Verlinsky, Y., Yang-Feng, T., Schonberg, S.A., Babu, A., Tharapel, A., Dorfmann, A.D., Lubs, H.A., Rhoads, G.G., Fowler, S.E. and de la Cruz, F., “Cytogenetic Results from the U.S. Collaborative Study on CVS,” Prenat Diagn, Vol. 12, 1992, pp. 317-345.
29. Levinson, G., Fields, R., Maddalena, A., Fugger, E.F., Harton, G.L., Palmer, F.T. and Schulman, J.D., “Reliable Genetic Screening of Human Preimplantation Embryos,” From Gametes to Embryos, Prenatal Diagnosis Symposium, Supplement Vol. 12, Milano, Italy, 1992, p. S110.
30. Levinson, G., Maddalena, A., Howard-Peebles, P.N., Black, S.H., Fugger, E.F., Palmer, F.T., Harton, G.L., Fields, R., Neel, B.L., Clifford, N.D. and Schulman, J.D., “Preimplantation Genetic Screening: an Option for Families at Risk for Transmission of the Fragile X Chromosome,” in Hagerman, R.J. and McKenzie, P. (eds.), 1992 International Fragile X Conference Proceedings, Spectra Publishing Co., Dillon, CO, 1992, p. 383.
31. Levinson, G., Maddalena, A., Palmer, F.T., Harton, G.L., Bick, D.P., Howard-Peebles, P.N., Black, S.H. and Schulman, J.D., “Sizing Fragile X Premutations and Normal Alleles with Nested PCR,” in Hagerman, R.J. and McKenzie, P. (eds.), 1992 International Fragile X Conference Proceedings, Spectra Publishing Co., Dillon, CO, 1992, p. 385.
32. Levinson, G., Fields, R.A., Harton, G.L., Palmer, F.T., Maddalena, A., Fugger, E. and Schulman, J.D., “Reliable Gender Screening for Human Preimplantation Embryos, using Multiple DNA Target-sequences,” Human Reprod, Vol. 7, 1992, pp. 1304-1313.
33. Levinson, G., Hughes, A.L. and Letvin, N.L., “Sequence and Diversity of Rhesus Monkey T-cell Receptor Beta Chain Genes,” Immunogenet, Vol. 35, 1992, pp. 75-88.
34. Maddalena, A. and Sherins, R.J., “Cystic Fibrosis (CFTR) Mutations in Men with Congenital Absence of the Vas Deferens,” Amer J Human Genet, Vol. 51, 1992, p. A340.
35. Maddalena, A., Black, S.H., Bick, D.P., Schulman, J.D. and Howard-Peebles, P.N., “Carrier Testing of Persons with Suggestive Family Histories Confirms a High Frequency of Fragile X,” in Hagerman, R.J. and McKenzie, P. (eds.), 1992 International Fragile X Conference Proceedings, Spectra Publishing Co., Dillon, CO, 1992, p. 381.
36. Maddalena, A., Black, S.H., Bick, D.P., Schulman, J.D. and Howard-Peebles, P.N., “Fragile X Screening in an Obstetrical Population Selected for Suggestive Family Histories,” 24th Annual March of Dimes-Clinical Genetics Conference, Stanford, CA, July 1992.
37. Fugger, E.F., Hazelrigg, W.B., Kraynick, J., Pool, S.H., Stone, Jr., G. and Schulman, J.D., “Effect of Monthly Variation on Fresh and Frozen-thawed Semen Characteristics from 280 Donors and 19,178 Specimens over a 4-1/2 Year Period,” 48th Annual Meeting of American Fertility Society, 1992.
38. Maddalena, A. and Sherins, R.J., “Cystic Fibrosis Mutations are Common among Healthy Men with Congenital Absence of the Vas Deferens, and Suggest Caution in the use of Epididymal Sperm Aspiration in Management of such Patients,” American Society of Andrology, Washington, DC, March 1992.
39. Maddalena, A., Bick, D.P. and Schulman, J.D., “Molecular Diagnosis of Genetic Disease,” J Reprod Med, Vol. 37, 1992, pp. 437-444.
40. Pergament, E., Schulman, J.D., Copeland, K., Fine, B., Black, S.H. and Frederiksen, M., “The Risk and Efficacy of Chorionic Villus Sampling in Multiple Gestations,” Prenat Diagn, Vol. 12, 1992, pp. 377-384.
41. Schulman, J.D., Black, S.H. and Bick, D.P., “Selected Aspects of Risks of Chorionic Villus Sampling (CVS) in a Large Series,” 6th International Conference on Early Prenatal Diagnosis of Genetic Disease, Milan, Italy, May 1992.
42. Schulman, J.D. and Black, S.H., “Genetics of Some Common Inherited Diseases,” in Edwards, R.G. (ed.), Preimplantation Diagnosis of Human Genetic Disease, 1992, pp. 101-125.
43. Sherins, R.J., “Adverse Effects of Treatment: Gonadal Dysfunction,” in DeVita, V.T., Hellman, S. and Rosenberg, S.A. (eds.), Cancer: Principles and Practice of Oncology, 4th ed., J.B. Lippincott Co., Philadelphia, 1992, pp. 2395-2406.
44. Sherman, S.L., Barbi, G., Brondum-Nielsen, K., Brown, W.T., Carpenter, N.J., Chudley, A.E., Ferraz, O.P., Ferreira, P., Gustavason, K-H., Halliday, J., Hockey, A., Howard-Peebles, P.N., Jenkins, E., Kennerknecht, I., Kahkonen, M., Ladaique, P., Leisti, J., Maddalena, A., Mazurczak, T., Mattei, J-F., Mattina, T., McKinley, M.J., Murphy, P., Pellissier, M.C., Purvis-Smith, S., Robinson, H., Scapagnini, U., Schaap, T., Shapiro, L.R., Smits, A.P.T., Steinbach, P., Turner, G., Uchida, I.A., van Oost, B.A., Voelckel, M-A., Weaver, D.D. and Webb, T., “Collaborative Prospective Study of the Fragile X Syndrome: One-year Progress Report,” Amer J Med Genet. Vol. 43, 1992, pp. 355-360.
45. Stern, J.J. and Coulam, C.B., “Review: New Concepts in Ovarian Regulation: an Immune Insight,” Amer J Reprod Immunol, Vol. 27, 1992, pp. 136-144.
46. Stern, J.J. and Coulam, C.B., “Mechanism of Recurrent Spontaneous Abortion I: Ultrasonographic Findings,” Amer J Obstet Gynecol, Vol. 166, 1992, pp. 1844-1850.
47. Stern, J.J., Peters, A.J. and Coulam, C.B., “Color Doppler Ultrasonography Assessment of Tubal Patency: a Comparison Study with Traditional Techniques,” Fertil Steril, Vol. 58, 1992, pp. 897-900.

1993

1. Bick, D.P., “The X-linked Kallmann Gene: Homology to Neural Cell Adhesions Molecules,” Endocrine Society Meeting, Las Vegas, Nevada, June 1993.
2. Bick, D.P. and Ballabio, A., “Commentary: Bringing Kallmann Syndrome into Focus,” Amer J Neuroradiol, Vol. 14, 1993, pp. 852-854.
3. Black, S.H., Bick, D.P., Maddalena, A., Schulman, J.D. and Jones, S., “Letter to the Editor: Pregnancy Screening for Cystic Fibrosis,” Lancet, Vol. 30, 1993, p. 342.
4. Buehler, B.A., Bick, D.P. and Delimont, D., “Letter to the Editor: Prenatal Prediction of Risk of the Fetal Hydantoin Syndrome,” New Engl J Med, Vol. 322, 1993, pp. 1660-1661.
5. Bustillo, M. Soenksen, D. and Coulam, C.B., “Ultrasound Diagnosis of Cervical Diverticulum in Two Infertile Women,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
6. Bustillo, M., Stern, J.J., King, D. and Coulam, C.B., “Serum Progesterone and Estradiol Concentrations in the Early Diagnosis of Ectopic Pregnancy after In Vitro Fertilization/embryo Transfer,” Fertil Steril, Vol. 59, 1992, pp. 668-670.
7. Calvo, L., Dennison-Lagos, L., Banks, S.M., Fugger, E.F. and Sherins, R.J., “Chemical Composition and Protein Source in the Capacitation Medium Effect Significantly the Ability of Human Sperm to Undergo Follicular Fluid Induced Acrosome Reaction,” Human Reprod, Vol. 8, 1993, pp. 575-580.
8. Corson, S., Albrecht, B., Awadalla, S., Berkeley, A., Bustillo, M., Gast, M., Ginsburg, K., Goodman, N., Hesla, J., Massey, J., Muasher, S., Olive, D., Seibel, M., Soules, M., Steinberger, E., Steinkampf, M., Walters, C. and Werlin, L., “Efficacy of Metrodin HP in Hypothalamic-pituitary Dysfunction: Preliminary Results of a Multicentre Clinical Study in the USA,” ESHRE meeting, Thessalonika, Greece, 1993.
9. Coulam, C.B., “The Long-term Effects of Estrogen Deprivation,” 7th Annual Symposium, Hormones and Immune Function, Victoria, BC, Canada, July 1993.
10. Coulam, C.B. and Bustillo, M., “Transvaginal Ultrasonographic Diagnosis of Ectopic Pregnancy,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
11. Coulam, C.B. and Bustillo, M., “Ultrasonic Guided Uterine Curettage for Fetal Karyotyping,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
12. Coulam, C.B., “Ultrasonographic Findings of Pregnancies Lost during a Clinical Trial for Treatment of Recurrent Pregnancy Loss,” 2nd Annual Meeting of the GynecoRadiology Society, Montreal, Canada, October 1993.
13. Coulam, C.B. and Bustillo, M., “Comparison of Pulsatility Indexes on the Day of Oocyte Retrieval and Embryo Transfer,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
14. Coulam, C.B., Bustillo, M., Krysa, L.W. and Schulman, J.D., “Intravenous Immunoglobulin for IVF Failure: a Pilot Study,” American Fertility Society (49th Annual Meeting) and The Canadian Fertility & Andrology Society (39th Annual Meeting), Palais des Congres, October 1993.
15. Coulam, C.B., “Immunotherapy for Unexplained Infertility,” Fertility Society of Australia (XII Annual Meeting), and Australian Gynaecological Endoscopy Society (III Annual Scientific Meeting), November 1993.
16. Coulam, C.B., “Diagnosis and Treatment of Recurrent Spontaneous Abortion,” Fertility Society of Australia (XII Annual Meeting) and Australian Gynaecological Endoscopy Society (III Annual Scientific Meeting), November 1993.
17. Coulam, C.B., “Immunotherapy for Recurrent Spontaneous Abortion,” Serono Symposium, Boston, MA, August 1993.
18. Ferre, M.M., Keene, C.L., Jewell, A.J. and Stetka, D.G., “Prenatal Diagnosis of 46,XX,i(18q) Associated with Holoprosencephaly and Cyclopia,” Amer J Human Genet, Vol. 53, No. 3, 1993.
19. Fisch, G.S., Holden, J.J.A., Simensen, R., Carpenter, N.J., Howard-Peebles, P.N., Maddalena, A., Sandgrund, A., Jacques, J.R. and McGann, B., “Is Fragile X Syndrome a Pervasive Developmental Disability? Cognitive and Adaptive Abilities in Males with the Full Mutation,” Amer J Human Genet, Vol. 53, No. 3, Abstract #432, 1993.
20. Fugger, E.F., Maddalena, A. and Schulman, J.D., “Results of Retroactive Testing of Human Semen Donors for Cystic Fibrosis (CF) and Human Immunodeficiency Virus (HIV) by Polymerase Chain Reaction (PCR),” Human Reprod, Vol. 8, 1993, pp. 1435-1437.
21. Gleicher, N., Confino, E., Corfman, R., Coulam, C., De Cherney, A., Haas, G., Katz, E., Robinson, E., Tur-Kaspa, I. and Vermesh M., “The Multicenter Transcervical Balloon Tuboplasty (TBT) Study: Conclusions and Comparison to Alternative Technologies,” Human Reprod, Vol. 8, 1993, pp. 1264-1271.
22. Heuertz, S., Nelen, M., Wilkie, A.O.M., Le Merrer, M., Del Rieu, O., Larget-Piet, L., Tranebjaerg, L., Bick, D.P., Hamel, B., van Oost, B.A., Maroteaux, P. and Hors-Cayla, M.C., “The Gene for Spondyloepiphyseal Dysplasia (SEDL) Maps to Xp22 between DXS16 and DXS92,” Genomics, Vol. 18, 1993, pp. 100-104.
23. Holowinsky, S., Black, S.H., Howard-Peebles, P.N., Mutirangua, A., Christian, S., Ledbetter, D.H. and Reynolds, J., “Triplication 15ql1-13 in Two Unrelated Patients with Hypotonia, Cognitive Delays and Visual Impairment,” Amer J Human Genet, Vol. 53, No. 3, Abstract #125, 1993.
24. Howard-Peebles, P.N., Maddalena, A., Black, S.H. and Schulman, J.D., “Population Screening for Fragile-X Syndrome,” Lancet, Vol. 341, 1993, p. 770.
25. Johnson, L.A., Welch, G.R., Keyvanfar, K., Dorfmann, A.D., Fugger, E.F. and Schulman, J.D., “Flow Separation of Human X-and Y-chromosome Bearing Sperm Validated with DNA Probes for Prevention of X-linked Disease,” Amer J Human Genet, Vol. 53, No. 3, Abstract #1422, 1993.
26. Johnson, L.A., Welch, G.R., Keyvanfar, K., Dorfmann, A., Fugger, E.F. and Schulman, J.D., “Gender Preselection in Humans? Flow Cytometric Separation of X and Y Spermatozoa for the Prevention of X-linked Diseases,” Human Reprod, Vol. 8, 1993, pp. 1733-1739.
27. Kalousek, D.K., Langlois, S., Barrett, I., Yam, I., Wilson, D.R., Howard-Peebles, P.N., Johnson, M-P. and Giorgiutti, E., “Uniparental Disomy for Chromosome 16 in Humans,” Amer J Human Genet, Vol. 52, 1993, pp. 8-16.
28. Kirk, E.P., Chuong, C.J., Coulam, C.B. and Williams, T.J., “Pregnancy after Metroplasty for Uterine Anomalies,” Fertil Steril, Vol. 59, 1993, pp. 1164-1168.
29. Maddalena, A., Spence, W.C., Levinson, G. and Howard-Peebles, P.N., “Fragile X Prenatal Diagnosis in Known Carriers,” Amer J Human Genet, Vol. 53, No. 3, Abstract #88, 1993.
30. Rizzo, W.B., Craft, D.A., Kelson, T.L., Bonnefont, J.P., Saudubray, J.M., Schulman, J.D., Black, S.H., Tabsh, K. and Di Rocco, M., “Prenatal Diagnosis of Sjogren-Larsson Syndrome in the First and Second Trimester using Enzymatic Methods,” Amer J Human Genet, Vol. 53, No. 3, Abstract #89, 1993.
31. Saaranen, M.J., Calvo, L., Dennison, L., Banks, S., Bustillo, M., Dorfmann, A.D., Goldstein, M., Thorsell, L., Schulman, J.D. and Sherins, R.J., “Acrosome Reaction Inducing Activity in Follicular Fluid Correlates with Progesterone Concentration but not with Oocyte Maturity or Fertilizability,” Human Reprod, Vol. 8, 1993, pp. 1448-1454.
32. Schnur, R.E., Wick, P.A., Sosnoski, D.N., Ballabio, A., Bick, D.P. and Nussbaum, R.L., “Deletion Mapping and a Highly Reduced Radiation Hybrid in the Xp22.2-p22.3 Region,” Genomics, Vol. 15, 1993, pp. 500-506.
33. Schulman, J.D., “Galactosemia: New Frontiers in Research,” National Institutes of Health, 1993.
34. Schulman, J.D., “Ethical Issues in Gender Selection by X/Y Sperm Separation,” Human Reprod, Vol. 8, 1993, p. 1541.
35. Stern, J.J., Thorsell, L., Bustillo, M. and Coulam, C.B., “Validation of an Embryo Toxicity Assay,” Amer Soc Reprod Immunol Meeting, 1993.
36. Stern, J.J., Bustillo, M. and Coulam, C.B., “Color Doppler Ultrasound Guidance for Wire Tuboplasty,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
37. Stern, J.J. and Coulam, C.B., “When to Start Treatment after a Positive Anti-phospholipid (aPA),” Amer Soc Reprod Immunol Meeting, 1993.
38. Stern, J.J., Bustillo, M., Britten, S., Soenksen, D. and Coulam, C.B., “Color Doppler Hysterosalpingogram: 3 Years Experience,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
39. Stern, J.J., Soenksen, D., Britten, S., Bustillo, M. and Coulam, C.B., “Hysterosalpingogram: an Easy Way of Studying the Uterine Cavity,” 2nd Annual Meeting of GynecoRadiology Society, Montreal, Canada, October 1993.
40. Stern, J.J., Soenksen, D., Britten, S., Bustillo, M. and Coulam, C.B., “Hysterosonogram: an Easy Way of Studying the Uterine Cavity,” American Fertility Society (49th Annual Meeting) and The Canadian Fertility & Andrology Society (39th Annual Meeting), Palais des Congres, October 1993.
41. Stern, J.J., Voss, F. and Coulam, C.B., “Early Diagnosis of Ectopic Pregnancy using Receiver-operator Characteristic Curves of Serum Progesterone Concentrations,” Human Reprod, Vol. 8, 1993, pp. 775-779.
42. Stern, J.J., Bustillo, M. and Coulam, C.B., “Color Doppler Ultrasound Guidance for Wire Tuboplasty,” Human Reprod, Vol. 8, 1993, pp. 1715-1718.
43. Stern, J.J. and Coulam, C.B., “Current Status of Immunologic Recurrent Pregnancy Loss,” Current Opinion Obstet Gynecol, Vol. 5, 1993, pp. 252-259.
44. Stetka, D.G., Bick, D.P., Meck, J.M., Baty, E.B. and Schulman, J.D., “Two Cases of Mosaic Variegated Aneuploidy with Microcephaly: a Mutation that Results in Mitotic Non-disjunction?,” Amer J Human Genet, Vol. 53, No. 3, Abstract #604, 1993.

1994

1. Barnea, E.R., Lahijani, K.I., Roussev, R., Barnea, J.D. and Coulam, C.B., “Identification and Validation of an Assay for Preimplantation Factor (PIF),” 2nd World Conference on Implantation & Early Pregnancy in Humans, Atlantic City, NJ, May 1994.
2. Barnea, E.R., Lahijani, K.I., Roussev, R.G., Barnea, J.D. and Coulam, C.B., “Identification and Validation of an Assay for Preimplantation Factor (PIF),” Soc Gyn Investigation, 41st Annual Meeting, Chicago, IL, March 1994.
3. Barnea, E.R., Lahijani, I., Roussev, R., Barnea, J.D. and Coulam, C.B., “Use of Lymphocyte Platelet Binding Assay for Detecting a Preimplantation Factor: a Quantitative Assay,” Amer J Reprod Immunol, Vol. 32, 1994, pp.133-138.
4. Belker, A.M., Sherins, R.J., Bustillo, M. and Calvo, L., “Pregnancy with Microsurgical Vas Sperm Aspiration from a Patient with Neurological Ejaculatory Dysfunction,” J Androl, Vol. 15, 1994, pp. 65-69, 1994.
5. Black, S.H., Maddalena, A., Howard-Peebles, P.N., Bick, D.P., Levinson, G. and Schulman, J.D., “Fragile X Screening in an Obstetric Population,” Amer J Med Genet, Vol. 51, 1994, p. 607.
6. Black, S.H., Fallon, L., Cummings, E., Menapace-Drew, G., Maddalena, A., Spence, W.C., Bick, D.P., Levinson, G., Howard-Peebles, P.N. and Schulman, J.D., “Molecular Fragile X Screening in Pregnancy and Egg Donor Populations,” Amer J Human Genet, Vol. 55, 1994, p. A10.
7. Black, S.H., “Preimplantation Genetic Diagnosis,” Current Opinion Pediat Current Sci, Vol. 6, 1994, pp. 712-716.
8. Britten, S., Soenksen, D.M., Bustillo, M. and Coulam, C.B., “Very Early (24-56 days from last menstrual period) Embryonic Heart Rate in Normal Pregnancies,” Human Reprod, Vol. 9, 1994, pp. 2424-2426.
9. Bustillo, M., Coulam, C.B. and Krysa, L.W., “Uterine Receptivity in an Oocyte Donation Program,” Soc Gyn Investigation, March 1994.
10. Calvo, L., Dennison, L., Banks, S., Dorfmann, A., Thorsell, L., Bustillo, M. and Sherins, R., “Acrosome Reaction Predicts Fertilization at IVF,” American Society of Andrology, Springfield, IL, March 1994.
11. Calvo, L., Dennison-Lagos, L., Banks, S.M. and Sherins, R.J., “Characterization and Frequency Distribution of Sperm Acrosome Reaction among Normal Men and Men with Infertility,” Human Reprod, Vol. 9, 1994, pp. 1875-1879.
12. Calvo, L., Dennison-Lagos, L., Banks, S.M., Dorfmann, A., Thorsell, L.P., Bustillo, M., Schulman, J.D. and Sherins, R.J., “Acrosome Reaction Inducibility Predicts Fertilization Success at IVF,” Human Reprod, Vol. 9, 1994, pp. 1880-1886.
13. Cole, H., Huang, B., Salbert, B.A., Brown, J., Howard-Peebles, P.N., Black, S.H., Dorfmann, A., Febles, O.R., Stevens, C.A. and Jackson-Cook, C., “Mental Retardation and Ullrich-Turner Syndrome in Cases with 45,X/46,X,+mar: Additional Support for the Loss of the X-inactivation Center Hypothesis,” Amer J Med Genet, Vol. 52, 1994, pp. 136-145.
14. Coulam, C.B., “Worldwide Collaborative Observational Study and Meta-analysis on Allogenic Leukocyte Immunotherapy for Tecurrent Spontaneous Abortion,” Recurrence Miscarriage Immunotherapy Trialists Group, AJRI Press Conference, Chicago, IL, October 1994.
15. Coulam, C.B., “Hysterosonogram: a Simple Method of Assessing the Uterine Cavity,” Annual Clinical Meeting of Central Association of Obstetricians and Gynecologists, October 1994.
16. Coulam, C.B., Krysa, L.W. and Bustillo, M., “Intravenous Immunoglobulin for In-vitro Fertilization Failure,” American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
17. Coulam, C.B., Krysa, L., Roussev, R.G. and Thomasen, E.J., “Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy Loss Associated with Elevated Circulating CD56+ Cells,” American Fertility Society (50th Annual Meeting) San Antonio, TX, November 1994.
18. Coulam, C.B., Roussev, R., Thomasen, E.J. and Barnea, E.R., “Preimplantation Factor (PIF) Predicts Subsequent Pregnancy Loss,” American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
19. Coulam, C.B., Bustillo, M., Soenksen, D.M., Britten, S. and Goodman, C., “Ultrasonographic Predictors of Implantation after Assisted Reproduction,” American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
20. Coulam, C.B. and Soenksen, D.M., “Early Identification of Umbilical Cord using Color Doppler Energy (CDE),” 3rd Annual Meeting of GynecoRadiology Society, during American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
21. Coulam, C.B. and Soenksen, D.M., “Pulsatility Index of Vitelline Duct,” 3rd Annual Meeting of GynecoRadiology Society, during American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
22. Coulam, C.B., Goodman, C., Soenksen, D.M., Britten, S. and Bustillo, M., “Ultrasonographic Predictors of Implantation after Assisted Reproduction,” 3rd Annual Meeting of GynecoRadiology Society, during American Fertility Society (50th Meeting), San Antonio, TX, November 1994.
23. Coulam, C.B., Britten, S., Soenksen, D.M. and Bustillo, M., “Very Early (24 to 56 days from LMP) Embryonic Heart Rate in Normal Pregnancies,” 3rd Annual Meeting of GynecoRadiology Society, during American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
24. Coulam, C.B., Bustillo, M., Soenksen, D.M. and Britten, S., “Ultrasonographic Predictors of Implantation after Assisted Reproduction,” 2nd World Conference on Implantation & Early Pregnancy in Humans, Atlantic City, NJ, May 1994.
25. Coulam, C.B., “Use of Vaginal Ultrasound in an Office Setting,” Controversies in Obstetrics & Gynecology, Southampton Princess, Bermuda, April 1994.
26. Coulam, C.B., Britten, S., Soenksen, D.M. and Bustillo, M., “Very Early (24 to 56 days from LMP) Embryonic Heart Rate in Normal Pregnancies,” American Institute of Ultrasound in Medicine, Baltimore, MD, March 1994.
27. Coulam, C.B., Bustillo, M. and Krysa, L.W., “Intravenous Immunoglobulin for IVF Failure,” American Society for Reproductive Immunology, 14th Annual Meeting, Philadelphia, PA, June 1994.
28. Coulam, C.B. and Soenksen, D.M., “Comparison of Pulsatility Indexes on the Day of Oocyte Retrieval and Embryo Transfer,” American Institute of Ultrasound in Medicine, Baltimore, MD, March 1994.
29. Coulam, C.B., Krysa, L., Stern, J.J. and Bustillo, M., “Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy Loss,” International Roundtable-Intravenous Immunoglobulin, Spain, June 1994.
30. Coulam, C.B., Roussev, R.G., Thomason, E.J. and Beaman, K.G., “Systemic CD56+ cells can Predict Pregnancy Outcome,” American Society for Reproductive Immunology, 14th Annual Meeting, Philadelphia, PA, June 1994.
31. Coulam, C.B. and Bustillo, M. “Ultrasonic Guided Uterine Curettage for Fetal Karyotyping,” American Institute of Ultrasound in Medicine, Baltimore, MD, 1994, pp. 20-23.
32. Coulam, C.B., Bustillo, M., Soenksen, D.M. and Britten, S., “Ultrasonographic Predictors of Implantation after Assisted Reproduction,” Soc Gyn Investigation, March 1994.
33. Coulam, C.B. and Bustillo, M., “Transvaginal Ultrasonographic Diagnosis of Ectopic Pregnancy,” Controversies in Obstetrics & Gynecology, Southampton Princess, Bermuda, April 1994.
34. Coulam, C.B. and Stern, J.J., “Effect of Seminal Plasma on Implantation Rates,” 2nd World Conference on Implantation & Early Pregnancy in Humans, Atlantic City, NJ, May 1994.
35. Coulam, C.B., Bustillo, M. and Krysa, L.W., “Effects of Intravenous Immunoglobulin on Implantation after IVF Failure,” 2nd World Conference on Implantation & Early Pregnancy in Humans, Atlantic City, NJ, May 1994.
36. Coulam, C.B. and Stern, J.J., “Endocrine Factors Associated with Recurrent Spontaneous Abortion,” Clinical Obstet Gynecol, Vol. 37, 1994, pp. 730-744.
37. Coulam, C., Stern, J. and Bustillo, M., “Ultrasonographic Findings of Pregnancy Losses after Treatment for Recurrent Pregnancy Loss: Intravenous Immunoglobulin Versus Placebo,” Fertil Steril, Vol. 61, 1994, pp. 248-251.
38. Coulam, C.B. and Tung, K.S.K., “Autoimmune Basis of Premature Ovarian Failure,” Autoimmunity Reprod, Vol. 14, 1994, pp. 739-752.
39. Coulam, C.B., Bustillo, M., Soenksen, D.M. and Britten, S., “Ultrasonographic Predictors of Implantation after Assisted Reproduction,” Fertil Steril, Vol. 62, 1994, pp. 1004-1010.
40. Coulam, C.B., “Immunotherapy for Recurrent Spontaneous Abortion,” in Hunt, J. (ed.), Immunobiology of Reproduction, Vol. 19, 1994, pp. 303-315.
41. Coulam, C.B., Krysa, L.W. and Bustillo, M., “Intravenous Immunoglobulin for In-vitro Fertilization Failure,” Human Reprod, Vol. 9, 1994, pp. 2265-2269.
42. Coulam, C.B. and Clark, D.A., “Editorial: Immunotherapy for Recurrent Miscarriage,” Amer J Reprod Immunol, Vol. 32, 1994, pp. 257-260.
43. Coulam, C.B., “Alternative Treatment to Lymphocyte Immunization for Treatment of Recurrent Spontaneous Abortion. Immunotherapy with Intravenous Immunoglobulin Treatment of Recurrent Pregnancy Loss: American Experience,” Amer J Reprod Immunol, Vol. 32, 1994, pp. 286-289.
44. Fisch, G.S, Snow, K., Thibodeau, S.N., Chalifaux, M., Holden, J.J.A., Nelson, D.L. and Howard-Peebles, P.N., “Fragile X Premutation in Parents and its Effect on Size in Offspring with the Mutation,” Amer J Human Genet, Vol. 55, 1994, p. A39.
45. Fisch, G.S., Holden, J.J.A., Simensen, R., Carpenter, N., Howard-Peebles, P.N., Maddalena, A., Sandgrund, A., Jacques, J.R. and McGann, B., “Is Fragile X Syndrome a Pervasive Developmental Disability? Cognitive Ability and Adaptive Behavior in Males with the Full Mutation,” Amer J Med Genet, Vol. 51, 1994, pp. 346-352.
46. Goodman, C., Britten, S., Soenksen, D.M. and Coulam, C.B., “Ultrasonographic Findings in Very Early (21 to 38 days from LMP) Normal Pregnancies,” 3rd Annual Meeting of GynecoRadiology Society, during American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
47. Howard-Peebles, P.N., Fallon, L., Black, S.H., Maddalena, A., Bick, D.P., Levinson, G. and Schulman, J.D., “Fragile X Carrier Screening in an Obstetric Population,” 4th International Fragile X Conference, Albuquerque, NM, June 1994.
48. Howard-Peebles, P.N. and Black, S.H., “FISH Identification of Deletion lp36 from a Half-cryptic Maternal Translocation,” American College of Medical Genetics, 1st Annual Meeting, Orlando, FL, March 1994, Amer J Med Genet, Vol. 52, 1994, p. 381.
49. Howard-Peebles, P.N., “The Fragile X Cytogenetic Test is Dead!,” Appl Cytogenet, Vol. 20, 1994, p. 61.
50. Howard-Peebles, P.N., Maddalena, A., Spence, W.C., Levinson, G., Fallon, L., Bick, D.P., Black, S.H. and Schulman, J.D., “Letter to the Editor: Fragile X Screening: What is the Real Issue?,” Amer J Med Genet, Vol. 53, 1994, p. 382.
51. Howard-Peebles, P.N., “Fragile X,” in B.J. and Dale, K.S. (eds.), The Cytogenetic Svmposia 1994, Kaplan, Burbank, CA, 1994.
52. Johnson, L.A. and Schulman, J.D., “Human Sperm Sex Selection. The Safety of Sperm Selection by Flow Cytometry,” Human Reprod, Vol. 9, 1994, pp. 758-759.
53. Jones, S.L., “Assisted Reproductive Technologies: Genetic Counseling and Nursing Implications,” JOGNN, Vol. 23, 1994, pp. 493-497.
54. Jones, S.L., “Genetic-based and Assisted Reproductive Technology of the 21st Century,” JOGNN, Vol. 23, 1994, pp. 160-165.
55. Kalousek, D.K., Langlois, S., Harrison, K.J., Wilson, R.D., McGillivray, B.C., Yong, S.L., Barrett, I.J., Johnson, M. and Howard-Peebles, P.N., “Confined Placental Mosaicism and Uniparental Disomy,” Amer J Human Genet, Vol. 55, 1994, p. A9.
56. Levinson, G., Reading, J.P., Huffman, J.L., Wu, J.C., Sisson, M.E., Palmer, F.T., Harton, G.L., Keyvanfar, K., Black, S.H. and Schulman, J.D., “Erythroid Progenitors in Maternal Blood and Analysis of Fetal Origins,” 7th International Conference on Early Prenatal Diagnosis, Jerusalem, Israel, May 1994.
57. Levinson, G., “Crossovers Generate Non-random Mutations under Darwinian Selection,” Artificial Life IV, Proceedings of an interdisciplinary workshop on the synthesis and simulation of living systems, July 1994, Brooks, R. and Maes, P. (eds.), Cambridge, MA: M.I.T., 1994, pp. 90-101.
58. Levinson, G., Maddalena, A., Palmer, F.T., Harton, G.L., Bick, D.P., Howard-Peebles, P.N., Black, S.H. and Schulman, J.D., “Improved Sizing of Fragile X CCG Repeats by Nested PCR,” Amer J Med Genet, Vol. 51, 1994, pp. 527-534.
59. Maddalena, A., Hicks, B.D., Spence, W.C., Levinson, G. and Howard-Peebles, P.N., “Prenatal Diagnosis in Known Fragile X Carriers,” Amer J Med Genet, Vol. 51, 1994, pp. 490-496.
60. Meck, J.M., Kozina, C., Stratakis, C., Garnica, A., Bick, D., Motz, M.K., Qin, N. and Rennert, O., “Mosaic Variegated Aneuploidy with Microcephaly: a Rare Cytogenetic Syndrome,” Amer J Human Genet , Vol. 55, 1994, p. A111.
61. Opsahl, M.S., Cunningham, D.S., Robins, E.D., Scott, R.T. and Fritz, M.A., “Sonographic Characteristics of Endometrial and Follicular Development in Serial Clomiphene Citrate-induced Cycles,” Soc Gyn Investigation, March 1994, p. P-069.
62. Park, V., Howard-Peebles, P., Sherman, S., Taylor, A. and Wulfsberg, E., “Policy Statement: American College of Medical Genetics. Fragile X Syndrome: Diagnostic and Carrier Testing,” Amer J Med Genet, Vol. 53, 1994, p. 380-381.
63. Rizzo, W.B., Craft, D.A., Kelson, T.L., Bonnefont, J-P., Saudubray, J-M., Schulman, J.D., Black, S.H., Tabsh, K., DiRocco, M. and McKinlay Gardner, R.J., “Prenatal Diagnosis of Sjogren-Larsson Syndrome using Enzymatic Methods,” Prenat Diagn, Vol. 14, 1994, pp. 577-581.
64. Rousseau F., Heitz, D., Tarleton, J., MacPherson, J., Malmgren, H., Dahl, N., Barnicoat, A., Mathew, C., Mornet, E., Tejada, I., Maddalena, A., Spiegel, R., Schinzel, A., Marcos, J.A.G., Schorderet, D.F., Schaap, T., Maccioni, L., Russo, S., Jacobs, P.A., Schwartz, C. and Mandel, J.L., “A Multicenter Study on Genotype-phenotype Correlations in the Fragile X Syndrome using Direct Diagnosis with Probe StB12.3: the First 2253 Cases,” Amer J Human Genet, Vol. 55, 1994, pp. 225-237.
65. Roussev, R.G., Barnea, E., Thomason, E.J. and Coulam, C.B., “Clinical Validation of Preimplantation Factor (PIF) Assay,” 2nd World Conference on Implantation & EarlyPregnancy in Humans, Atlantic City, NJ, May 1994.
66. Roussev, R.G., Barnea, E., Thomason, E.J. and Coulam, C.B., “A Novel Bioassay for Detection of Preimplantation Factor (PIF),” American Society for Reproductive Immunology, 14th Annual Meeting, Philadelphia, PA, June 1994.
67. Roussev, R.G., Thomason, E.J., Stern, J.J. and Coulam, C.B., “Antiendothelial Antibodies (IgG) In Sera from Secondary Recurrent Spontaneous Aborters,” 14th Annual Meeting, American Society for Reproductive Immunology, Philadelphia, PA, June 1994.
68. Schwartz, C.E., Dean, J., Howard-Peebles, P.N., Bugge, M., Mikkelsen, M., Tomerup, N., Hull, C., Hagerman, R., Holden, J.J.A. and Stevenson, R.E., “Obstetrical and Gynecological Problems in Fragile X Carriers: a Multicenter Study,” Amer J Med Genet, Vol. 51, 1994, pp. 400-402.
69. Sherins, R.J., Thorsell, L., Dorfmann, A., Dennison, L., Coulam, C.B. and Schulman, J.D., “Intracytoplasmic Sperm Injection (ICSI) Facilitates Fertilization and Pregnancy even in the most Severe Forms of Male Infertility,” American Fertility Society (50th Annual Meeting), San Antonio, TX, November 1994.
70. Sherins, R.J., “Evaluation of Sperm Fertilizing Capacity,” Advances in Assisted Reproductive Technology, AFS/SART Post Graduate Course, San Antonio, November 1994.
71. Sherins, R.J., “The Sperm Micro-aspiration Retrieval Techniques Study Group. Results in the United States with Sperm Micro-aspiration Retrieval Techniques and Assisted Reproductive Technologies,” J Urol, Vol. 151, 1994, pp. 1255-1259.
72. Sherins, R.J., “Intracytoplasmic Sperm Injection,” Advances in Assisted Reproductive Technology, AFS/SART Post Graduate Course, San Antonio, November 1994.
73. Sherins, R.J., “How is Male Infertility Defined and Evaluated?,” Handbook of Andrology, American Society of Andrology, 1994, pp. 48-51.
74. Sherman, S.L., Maddalena, A., Howard-Peebles, P.N., Brown, W.T., Nolin, S., Jenkins, E., Schwartz, C., Tarrelton, J., Shapiro, L.R., Smits, A.P.T., van Oost, B.A., Youings, S., Jacobs, P.A., Martinez, F., Barnicoat, A., Hockey, A., Staley, L., Hagerman, R., Kennerknecht, I., Steinback, P., Barbi, G., Filippi, G., Grasso, M., Taylor, S.A.M., Robinson, H., Webb, T., Broome, D., Dixon, J., Ferreira, P., Gustavson, K.H., Meyer, J.L. and Pai, G.S., “Characteristics of the Transmission of the FMR1 Gene from Carrier Females in a Prospective Sample of Conceptuses,” Amer J Med Genet, Vol. 51, 1994, pp. 503-506.
75. Sozer, A.C. and Demers, D.B. Molecular analysis of genetic diversity. In: Current Protocols in Human Genetics. Dracopoli, N.C., Haines, J.L., Korf, B.R., Moir, D.T., Morton, C.C., Seidman, C.E., Seidman, J.G. and Smith, D.R., eds., p. 9.7.1-9.7.14., John Wiley & Sons, Inc., New York, 1994.
76. Spence, W.C., Maddalena, A., Demers, D.B. and Bick, D.P., “Prenatal Determination of the Genotype in Fetuses at Risk for RhD and RhE Hemolytic Disease of the Newborn,” Amer J Human Genet, Vol. 55, 1994, p. A19.
77. Spence, W.C., Maddalena, A., Demers, D.B. and Bick, D.P., “Molecular Analysis of the Rh Locus in an Individual with the Du Phenotype,” Transfusion, Vol. 34, 1994, pp. 741-742.
78. Stern, J.J., Soenlisen, D., Britten, S., Bustillo M. and Coulam C.B., “Hysterosonogram: an Easy Way of Studying the Uterine Cavity,” Controversies in Obstetrics & Gynecology, Southampton Princess, Bermuda, April 1994.
79. Stern, J.J., Soenksen, D., Britten, S., Bustillo, M. and Coulam, C.B., “Hysterosonogram: an Easy Way of Studying the Uterine Cavity,” American Institute of Ultrasound in Medicine, Baltimore, MD, March 1994.
80. Stern, J.J., Bustillo, M. and Coulam, C.B., “Color Doppler Ultrasound Guidance for Wire Tuboplasty,” American Institute of Ultrasound in Medicine, Baltimore, MD, March 1994.
81. Stern, J.J., Bustillo, M., Britten, S., Soenksen, D. and Coulam, C.B., “Color Doppler Hysterosalpingogram: 3 Years Experience,” American Institute of Ultrasound in Medicine, Baltimore, MD, March 1994.
82. Stern, J.J., Bustillo, M., Britten, S., Soenksen, D. and Coulam, C.B., “Color Doppler Hysterosalpingogram: 3 Years Experience,” Controversies in Obstetrics & Gynecology, Southampton Princess, Bermuda, April 1994.
83. Stern, J.J., Bustillo, M. and Coulam, C.B., “Color Doppler Ultrasound Guidance for Wire Tuboplasty,” Controversies in Obstetrics & Gynecology, Southampton Princess, Bermuda, April 1994.
84. Thomason, E.J., Roussev, R.G., Stern, J.J. and Coulam, C.B., “The Prevalence of Embryotoxicity In Sera of Women with Recurrent Spontaneous Abortion,” 14th Annual Meeting, American Society for Reproductive Immunology, Philadelphia, PA, June 1994.

1995

1. Barrett, I.J., Kalousek, D.K., Telenius, A. and Howard-Peebles, P.N., “Cell Lineages Involved in CVS Mosaicism and Pregnancy Outcome,” Amer J Human Genet, Vol. 57, 1995, p. A275.
2. Bick, D.P., “Challenges and Opportunities,” IEEE Engineering Med Bio, Vol. 14, No. 2, 1995, pp. 226-228.
3. Black, S.H., Levinson, G., Harton, G.L., Palmer, F.T., Sisson, M.E., Schoener, C., Nance, C., Fugger, E.F. and Fields, R.A., “Preimplantation Genetic Testing (PGT) for Fragile X (fraX),” Amer J Human Genet, Vol. 57, 1995, p. A31.
4. Britten, S., Soenksen, D.M. and Coulam, C.B., “Early (34 to 56 days from LMP) Ultrasonographic Measurements in Normal Pregnancies,” 4th Annual Meeting of GynecoRadiology Society, Seattle, WA, October 1995.
5. Bustillo, M., Krysa, L.W. and Coulam, C.B., “Uterine Receptivity in an Oocyte Donation Programme,” Human Reprod, Vol. 10, 1995, pp. 442-445.
6. Cauchi, M.N., Coulam, C.B., Cowchock, S., Ho, H.N., Gatenby, P., Johnson, P.M., Lubs, M.L.E., McIntyre, J.A., Ramsden, G.H., Smith, J.B. and Sharpe, K., “Predictive Factors in Recurrent Spontaneous Aborters--a Multicenter Study,” Amer J Reprod Immunol, Vol. 33, 1995, pp. 165-170.
7. Christian, S.L., Smith, A.C.M., Black, S., Elder, F.F.B., Johnson, J.M.-P., Resta, R.G., Rocklin, M.L., Surti, U., Suslak, L., Verp, M.S., Wilkins, I. and Ledbetter, D.H., “Molecular Investigation of Mosaic Trisomy 15 Demonstrates Maternal MI Non-disjunction and High Risk for Uniparental Disomy 15,” Amer J Human Genet, Vol. 57, 1995, p. A34.
8. Coulam, C.B., Sherins, R.J., Thorsell, L.P., Dorfmann, A., Opsahl, M. and Schulman, J.D., “Comparisons of Pregnancy Loss Patterns and Karyotypes of Miscarriages in Pregnancies after Intracytoplasmic Sperm Injection (ICSI) and other Assisted Reproductive Technologies,” Pacific Coast Fertility Society, San Diego, CA, April 1995.
9. Coulam, C.B., Sherins, R.J., Thorsell, L.P., Dorfmann, A., Opsahl, M. and Schulman, J.D., “Pregnancy Loss Rates and Karyotypic Abnormalities after Intracytoplasmic Sperm Injection and Conventional IVF,” Soc Gynecol Investigation, 42nd Annual Meeting, Chicago, IL, March 1995, J Soc Gynecol Invest, Vol. 2, 1995, p. 140.
10. Coulam, C.B. and Beaman, K.D., “TJ6 CD19/CD56 Ratio Predicts Pregnancy Outcome,” Soc Gynecol Investigation, 42nd Annual Meeting, Chicago, IL, March 1995, J Soc Gynecol Invest, Vol. 2, 1995, p. 239.
11. Coulam, C.B., Roussev, R.G., Thomason, E.D. and Barnea, E.R., “Preimplantation Factor (PIF) Predicts Subsequent Pregnancy Loss,” Amer J Reprod Immuno, Vol. 34, 1995, pp. 88-92.
12. Coulam, C.B. and Beaman, K.D., “Reciprocal Alteration in Circulating TJ6+ CDl9+ and TJ6+ CD56+ Leukocytes in Early Pregnancy Predicts Success or Miscarriage,” Amer J Reprod Immunol, Vol. 34, 1995, pp. 219-224.
13. Coulam, C.B., “Implantation Failure and Immunotherapy,” Opin Human Reprod, Vol. 10, 1995, pp. 1338-1340.
14. Coulam, C.B., Stern, J.J., Soenksen, D.M., Britten, S. and Bustillo, M., “Comparison of Pulsatility Indices on the Day of Oocyte Retrieval and Embryo Transfer,” Human Reprod, Vol. 10, 1995, pp. 82-84.
15. Coulam, C.B., Goodman, C., Roussev, R.G., Thomason, E.D. and Beaman, K.D., “Systemic CD56+ Cells can Predict Pregnancy Outcome,” Amer J Reprod Immunol, Vol. 33, 1995, pp. 40- 46.
16. Coulam, C.B. and Stern, J.J., “Effect of Seminal Plasma on Implantation Rates,” Early Pregnancy: Biology and Medicine, Vol. 1, 1995, pp. 33-36.
17. Coulam, C.B., “Immunotherapy for Recurrent Spontaneous Abortion,” Early Pregnancy: Biology and Medicine, Vol. 1, 1995, pp. 13-26.
18. Demers, D.B., Curry, E.T. and Sozer, A.C., “Enhanced PCR Amplification of VNTR Loci using Peptide Nucleic Acid (PNA),” Amer J Human Genet, Vol. 57, 1995, p. A26.
19. Demers, D.B., Curry, E., Egholm, M. and Sozer, A.C., “Enhanced PCR Amplification of VNTR Locus DlS80 using Peptide Nucleic Acid (PNA),” Nucleic Acids Res, Vol. 23, 1995, pp. 3050-3055.
20. Fisch, G.S., Carpenter, N., Howard-Peebles, P.N., Maddalena, A., Simenson, R., Stanley, W.S., Burkett, S., Segel, B., Quiery, A., George, B., Lobel, J. and Shah, N., “Constitutional Chromosome Inversion 7 [(inv(7)(qll.2q22)] and Acute Leukemia,” Amer J Human Genet, Vol. 57, 1995, p. A77.
21. Fisch, G.S., Snow, K., Thibodeau, S.N., Chalifaux, M., Holden, J.J.A., Nelson, D.L., Howard-Peebles, P.N. and Maddalena, A., “The Fragile X Premutation in Carriers and its Effect on Mutation Size in Offspring,” Amer J Human Genet, Vol. 56, 1995, pp. 1147-1155.
22. Howard-Peebles, P.N., Stanley, W.S. and Dorfmann, A., “Variant or Real? The Clinical Cytogeneticist's Nightmare,” Amer J Human Genet, Vol. 57, 1995, p. A116.
23. Howard-Peebles, P.N., Maddalena, A., Black, S.H., Levinson, G., Bick, D.P. and Schulman, J.D., “Fragile X Screening in Pediatric & Obstetrical Patients,” Dev Brain Dysfunct, Vol. 8, 1995, pp. 408-410.
24.
25. Justus, A.C., Roussev, R.G., Norcross, J.L. and Faulk, W.P., “Antithrombin Binding by Human Umbilical Vein Endothelial Cells: Effects of Exogenous Heparin,” Thrombosis Res, Vol. 79, 1995, pp. 175-186.
26. Kaider, B.D., Roussev, R.G. and Coulam, C.B., “Antiphospholipid Antibody Prevalence in Patients with IVF Failure,” 6th Internat Congress Reprod Immunol, Washington, DC, Amer J Reprod Immunol, Vol. 33, 1995, p. 461.
27. Kaider, B.D., Roussev, R.G. and Coulam, C.B., “Laboratory Evaluation of Women Experiencing Reproductive Failure,” 6th Internat Congress Reprod Immunol, Washington, DC, Amer J Reprod Immunol, Vol. 33, 1995, p. 461.
28. King, D.A., Goldstein, M., Vanderlann, M., Siek, G. and Schulman, J.D., “Rapid Reliable Acetylcholinesterase (ACHE) Quantitation in Amniotic Fluid by Perfusion Chromatography Enzyme Immunoassay,” Amer J Human Genet, Vol. 57, 1995, p. A282.
29. Layman, L.C., Peak, D.B., Bick, D.P., Sherins, R.J., Gray, M.R. and Reindollar, R.H., “Analysis of the KAL Gene in Males and Females with Idiopathic Hypogonadotropic Hypogonadism,” Soc Gynecol Investigation, 42nd Annual Meeting, Chicago, IL, March 1995, J Soc Gynecol Invest, Vol. 2, 1995, p. 190.
30. Layman, L.C., Peak, D.B., Bick, D.P., Sherins, R.J., Gray, M.R. and Reindollar, R.H., “Exon Four Gonadotropin Releasing Hormone (GnRH) Gene Mutation in a Sample of 117 Patients with Idiopathic Hypogonadotropic Hypogonadism,” American Society for Reproductive Medicine, Seattle, WA, October 1995.
31. Levinson, G., Sisson, M.E., Harton, G.L., Palmer, F.T., Fields, R.A., Black, S.H., Fugger, E.F., Maddalena, A. and Schulman, J.D., “Preimplantation Genetic Testing for X-linked Disorders and Cystic Fibrosis,” 7th International Conference on Early Prenatal Diagnosis, Jerusalem, Israel, May 1995.
32. Levinson, G., Keyvanfar, K., Wu, J.C., Fugger, E.F., Fields, R.A., Harton, G.L., Palmer, F.T., Sisson, M.E., Starr, K.M., Dennison-Lagos, L., Calvo, L., Sherins, R.J., Bick, D., Schulman, J.D. and Black, S.H., “DNA-based X-enriched Sperm Separation as an Adjunct to Preimplantation Genetic Testing for the Prevention of X-linked Disease,” Mol Human Reprod, Vol. 1, 1995, pp. 979-982.
33. Levinson, G., “Artificial Life: Biotechnology of the 21st Century?,” Biotechnol, Vol. 13, 1995, pp. 122-123.
34. Levinson, G., “Rethinking Evolution. Computer Simulations Suggesting that Genetic Change is not Always Random give Modern Evolutionary Theory a Powerful Boost,” Washington Times, Washington, DC, The World & I, January 1995, p. 194-201.
35. Levinson, G., Coulam, C.B., Spence, W.C., Sherins, R.J. and Schulman, J.D., “Review: Recent Advances in Reproductive Genetic Technologies,” Biotechnol, Vol. 13, 1995, pp. 968-973.
36. Maddalena, A., Spence, W.C., Demers, D.B. and Bick, D.P., “Prenatal Detection of RhD, Rhc, RhE, and Kell Genotypes for Management of Pregnancies at Risk for Hemolytic Disease of the Newborn,” Amer J Human Genet, Vol. 57, 1995, p. A50.
37. Opsahl, M.S., Dorfmann, A.D., Thorsell, L.P., Coulam, C.B., Sherins, R.J. and Schulman, J.D., “Evidence for Embryo Selection Bias and Impaired Oocyte Reproductive Potential in Young Women Establishing Pregnancy with IVF or ICSI,” American Society for Reproductive Medicine, Seattle, WA, October 1995.
38. Opsahl, M.S., Bustillo, M. and Coulam, C.B., “Age Related Life Table Assessment of the Number of Embryos Necessary for Implantation using Patients who Ultimately Achieved a Clinical Pregnancy: Another Definition of In Vitro Fertilization (IVF) Failure,” Soc Gynecol Investigation, 42nd Annual Meeting, Chicago, IL, March 1995, J Soc Gynecol Invest, Vol. 2, 1995, p. 378.
39. Howard-Peebles, P.N., “It is Time to Abandon the Cytogenetic Fragile X test!,” Cytogenet Cell Genet, Vol. 69, 1995, p. 116.
40. Reading, J.P., Huffman, J.L., Wu, J.C., Palmer, F.T., Harton, G.L., Sisson, M.E., Keyvanfar, K., Gresinger, T.H., Cochrane, W.J., Fallon, L.A., Menapace-Drew, G.F., Cummings, E.A., Jones, S.L., Black, S.H., Schulman, J.D. and Levinson, G., “Nucleated Erythrocytes in Maternal Blood: Quantity and Quality of Fetal Cells in Enriched Populations,” Human Mol Reprod, Vol. 10, 1995, pp. 2510-2515.
41. Robare, R., Soenksen, D.M. and Coulam, C.B., “First Trimester Diagnosis of Acardiac Twins,” 4th Annual Meeting of GynecoRadiology Society, Seattle, WA, October 1995.
42. Roussev, R. G., “Preimplantation Factor,” 6th Internat Congress Reprod Immunol, Washington, DC, Amer J Reprod Immunol, Vol. 33, 1995, p. 433.
43. Roussev, R.G. and McIntyre, J.A., “Allotypic Antigen System Specific for Endothelial Cells,” AAP, ASCI and AFCR Clinical Research Meeting, San Diego, CA, May 1995.
44. Roussev, R.G. and Coulam, C.B., “Activation of Hemostatic and Fibrinolytic Markers on Endothelial Cells by Specific Anti-endothelial Cell Antibody,” AAP, ASCI and AFCR Clinical Research Meeting, San Diego, CA, May 1995.
45. Roussev, R.G., Goodman, C., Kaider, B.D., Barnea, E.R. and Coulam, C.B., “Embryonic Origin of Preimplantation Factor,” Soc Gynecol Investigation, 42nd Annual Meeting, Chicago, IL, March 1995, J Soc Gynecol Invest, Vol. 2, 1995, p. 358.
46. Roussev, R.G., Stern, J.J., Thorsell, L.P., Thomason, E.D. and Coulam C.B., “Validation of an Embryotoxicity Assay,” Amer J Reprod Immunol, Vol. 33, 1995, pp. 171-175.
47. Roussev, R.G., Barnea, E.R., Thomason, E.D. and Coulam C.B., “A Novel Bioassay for Detection of Preimplantation Factor (PIF),” Amer J Reprod Immunol, Vol. 33, 1995, pp. 68-73.
48. Schulman, J.D. and Sherins, R.J., “Autoreproduction by Hermaphrodites,” Human Reprod, Vol. 10, 1995, pp. 500-501.
49. Sherins, R.J., Thorsell, L.P., Dorfmann, A., Dennison-Lagos, L., Calvo, L.P., Krysa, L., Coulam, C.B. and Schulman, J.D., “Intracytoplasmic Sperm Injection Facilitates Fertilization Even in the Most Severe Forms of Male Infertility: Pregnancy Outcome Correlates with Maternal Age and Number of Eggs Available,” Fertil Steril, Vol. 64, 1995, pp. 360-368.
50. Sherins, R.J., “Are Semen Quality and Male Fertility Changing?,” New Engl J Med, Vol. 332, 1995, pp. 327-328.
51. Sherins, R.J., “How is Male Infertility Defined? How is it Diagnosed? Epidemiology, Causes, Work-up (history, physical, lab tests),” in Robaire, B., Pryor, J.L. and Trasler, J.M. (eds.), Handbook of Andrology--Defining Infertility in American Society of Andrologv, The American Society of Andrology, Allen Press, Lawrence, KS, 1995, p. 48-51.
52. Spence, W.C., Potter, P., Maddalena, A., Demers, D.B. and Bick, D.P., “DNA-based Prenatal Determination of the RhE Genotype,” Obstet Gynecol, Vol. 86, 1995, pp. 670-672.
53. Spence, W.C., Maddalena, A., Demers, D.B. and Bick, D.P., “Molecular Analysis of the RhD Genotype in Fetuses at Risk for RhD Hemolytic Disease,” Obstet Gynecol, Vol. 85, 1995, pp. 296-298.
54. Stern, J.J., Dorfmann, A., Gutierrez-Najar, A.J., Cerrillo, M. and Coulam, C.B., “Frequency of Abnormal Karyotypes among Abortuses from Women with and without a History of Recurrent Spontaneous Abortion,” Pacific Coast Fertility Society, San Diego, CA, April 1995.
55. Tarleton, J., Julien-Inalsingh, C., Chalifaux, M. and Holden, J.J.A., “Association Between Mutation Size and Cognitive/Behavioral Deficits in Fra(X) Males: a Prospective Multicenter Study,” Amer J Human Genet, Vol. 57, 1995, p. A337.
56. Thomason, E., Roussev, R.G., Stern, J.J. and Coulam, C.B., “Prevalence of Embryotoxic Factor In Sera from Women with Unexplained Recurrent Abortion,” Amer J Reprod Immunol, Vol. 34, 1995, pp. 388-391.
57. Thorsell, L.P., Dorfmann, A.D., Iwasko, M.A., Sherins, R.J., Coulam, C.B., Opsahl, M. and Schulman, J.D., “The Effects of Semen Quality on Embryo Morphology after ICSI,” 9th World Congress of IVF and Assisted Reproductive Technologies, Vienna, April 1995.
58. Vanderlann, M., Lotti, R., Siek, G., King, D. and Goldstein, M., “A Perfusion Immunoassay for Acetylcholinesterase: Analyte Detection Based on Intrinsic Activity,” J Chromatogr A, Vol. 711, 1995, pp. 23-31.

1996

1. Belker, A.M., Sherins, R.J., Coulam, C.B., Opsahl, M.S., Thorsell, L.P., Dorfmann, A.D. and Schulman, J.D., “High Fertilization and Pregnancy Rates Obtained by Nonsurgical Percutaneous Needle Aspiration of Testicular Sperm,” American Urological Association, Orlando, FL, May 1996.
2. Belker, A.M., Sherins, R.J. and Dennison-Lagos, L., “Simple, Rapid Staining Method for Immediate Intraoperative Examination of Testicular Biopsies,” J Andrology, Vol. 17, 1996, pp. 420-426.
3. Black, S.H., “Should We Offer Cystic Fibrosis and Fragile X Testing with all CVS and Amniocentesis?,” Baltimore Ultrasound Education and Research, 1996.
4. Burdette, D.E., Kremser, K., Fink, J.K., Pahan, K., Stanley, W. and Singh, I., “Late Onset Generalized Disorder of Peroxisomes,” Neurology, Vol. 46, 1996, pp. 831-839.
5. Christian, S.L., Smith, A.C.M., Macha, M., Black, S.H., Elder, F.F.B., Johnson, J.M-P., Resta, R.G., Surti, U., Suslak, L., Verp, M.S. and Ledbetter, D.H., “Prenatal Diagnosis of Uniparental Disomy 15 Following Trisomy 15 Mosaicism,” Prenat Diagn, Vol. 16, 1996, pp. 323-332.
6. Coulam, C.B., Opsahl, M.S. and Fugger, E.F., “Increased Preclinical Pregnancy Loss Rates after Embryo Transfer in Stimulated vs. Nonstimulated Cycles,” American Society for Reproductive Medicine, 52nd Annual Meeting, Boston, MA, November 1996.
7. Coulam, C.B., Sherins, R.J., Opsahl, M.S., Thorsell, L.P., Dorfmann, A., Krysa, L., Fugger, E. and Schulman, J.D., “Comparisons of Pregnancy Loss Patterns after Intracytoplasmic Sperm Injection and other Assisted Reproductive Technologies,” Fertil Steril, Vol. 65, 1996, pp. 1157-1160.
8. Demers, D.B., Sozer, A.C. and Howard-Peebles, P.N., “Detection and Characterization of Y-specific Repeat Sequences (DYZ1) in Two Phenotypically Normal Females,” International Society of Forensic Haemogenetics, 1996.
9. Demers, D.B., Curry, E.T. and Sozer, A.C., “Improved PCR Amplification of VNTR Locus D1S80 using PNA (Peptide Nucleic Acid) Oligomers,” 6th International Symposium on Human Identification, 1995, Promega Corporation, Madison, WI, 1996, p. 88-91.
10. Fisch, G. S., Simensen, R., Tarleton, J., Chalifoux, M., Holden, J.J.A., Carpenter, N., Howard-Peebles, P.N. and Maddalena, A., “Longitudinal Study of Cognitive Abilities and Adaptive Behavior Levels in Fragile X Males: a Prospective Multicenter Analysis,” Amer J Med Genet, Vol. 64, 1996, pp. 356-361.
11. Fisch, G. S., Carpenter, N., Howard-Peebles, P.N., Maddalena, A., Simensen, R., Tarleton, J., Julien-Inalsingh, C., Chalifoux, M. and Holden, J.J.A., “Lack of Association Between Mutation Size and Cognitive/Behavioral Deficits in Fragile X Males: a Brief Report,” Amer J Med Genet, Vol. 64, 1996, pp. 362-364.
12. Fisch, G.S., Carpenter, N., Maddalena, A., Tarleton, J., Julien-Inalsingh, C. and Holden, J.J.A., “Rater Reliability of Fragile X Mutation Size Estimates: a Multilaboratory Analysis,” Amer J Med Genet, Vol. 64, 1996, pp. 319-322.
13. Gentleman, S., Kaiser-Kupfer, M.I., Sherins, R.J., Caruso, R., Robison, W.G., Lloyd, R.A., Crawford, M.A., Pikus, A. and Chader, G.J., “Abnormal Microtubule Acetylation in an Infertile Male with a Retinal Degeneration,” Human Path, Vol. 27, 1996, pp. 80-84.
14. Howard-Peebles, P.N., “Letter to the Editor: Successful Pregnancy in a Fragile X Carrier by Donor Egg,” Amer J Med Genet, Vol. 64, 1996, p. 377.
15. Howard-Peebles, P.N., “Letter to the Editor: Other Possible Explanations for Cross-hybridization,” Prenat Diagn, Vol. 16, 1996, p. 577.
16. Howard-Peebles, P.N. and Black, S.H., “Reproductive Options for Fragile X Carriers,” Nat Fragile X Foundation Educa Files, Vol. 2, 1996, pp. 25-26.
17. Jones, S.L., “Advances in Human Genetics: Implications for Infertility in Nursing Practice,” Infert Reprod Med Clinics N Amer, Vol. 7, 1996, pp. 577-585.
18. Jones, S.L., “Genetics: Changing Health Care in the 21st Century,” JOGNN, Vol. 125, 1996, pp. 777-783.
19. Kaider, B.D., Purvis, M.T., Roussev, R.G. and Coulam, C.B., “Prevalence of Abnormal Immunologic Test Results in Women with Reproductive Failure,” American Society of Reproductive Immunology, 16th Annual meeting, Knoxville, TN, June 1996.
20. Kaider, B.D., Purvis, M.T., Kovacs, L., Coulam, C.B. and Roussev, R.G., “In-Vitro Effect of Anti-phospholipid, Anti-nuclear, and Anti-thyroid Antibodies upon Murine Cultured Embryos,” American Society of Reproductive Immunology, 16th Annual meeting, Knoxville, TN, June 1996.
21. Kalousek, D.K., Langlois, S., Robinson, W.P., Telenius, A., Bernard, L., Barrett, I.J., Howard-Peebles, P.N. and Wilson, R.D., “Trisomy 7 CVS Mosaicism: Pregnancy Outcome, Placental and DNA Analysis in 14 Cases,” Amer J Med Genet, Vol. 65, 1996, pp. 348-352.
22. Kilpatrick, M.W., Levinson, G., Black, S.H., Fugger, E.F., Schulman, J.D., Harton, G.L., Sisson, M.E., Starr, K.M., Mahoney, B.S. and Tsipouras, P., “Preimplantation Genetic Diagnosis in Marfan Syndrome,” Fetal Diagn Ther, Vol. 11, 1996, pp. 402-406.
23. Maddalena, A., Yadvish, K.N., Spence, W.C. and Howard-Peebles, P.N., “A Fragile X Mosaic Male with a Cryptic Full Mutation Detected in Epithelium but Not in Blood,” Amer J Med Genet, Vol. 64, 1996, pp. 309-312.
24. Opsahl, M.S., Schoener, C.J., Krysa, L.W., Thorsell, L.P., Dorfmann, A.D., Iwaszko, M.A. and Coulam, C.B., “Variability in Cycle Characteristics of Anonymous Oocyte Donors and the Effect of Cycle Variation on Pregnancy Rates,” American Society for Reproductive Medicine, 52nd Annual Meeting, Boston, MA, November 1996.
25. Opsahl, M.S., Dixon, N.G., Robins, E.R. and Cunningham, D.S., “Single vs. Multiple Semen Specimens in Screening for Male Infertility Factors,” J Reprod Med, Vol. 41, 1996, pp. 313-315.
26. Opsahl, M.S., Fitz, T.A., Rexroad, C.A. and Fritz, M.A., “Effects of Enclomiphene and Zuclomiphene on Basal and Gonadotropin-stimulated Progesterone Secretion by Isolated Subpopulations of Small and Large Ovine Luteal Cells,” Human Reprod, Vol. 11, 1996, pp. 1250-1255.
27. Opsahl, M.S., Robins, E.D., O'Connor, D.M., Scott, R.T. and Fritz, M.A., “Characteristics of Gonadotropin Response, Follicular Development, and Endometrial Growth and Maturation Across Consecutive Cycles of Clomiphene Citrate Treatment,” Fertil Steril, Vol. 66, 1996, pp. 533-539.
28. Purvis, M.T., Kaider, B.D., Roussev, R.G. and Coulam, C.B., “Antinuclear Antibody Prevalence in Patients with Reproductive Failure,” American Society of Reproductive Immunology, 16th Annual meeting, Knoxville, TN, June 1996.
29. Schulman, J.D., Black, S.H., Handyside, A. and Nance, W.E., “Preimplantation Genetic Testing for Huntington Disease and Certain Other Dominantly Inherited Disorders,” Clin Genet, Vol. 49, 1996, pp. 57-58.
30. Schulman, J.D. and Stern, H.J., “Genetic Predisposition Testing for Breast Cancer,” The Cancer Journal (Scientific American), Vol. 2, 1996, pp. 244-252.
31. Schulman, J.D., “What's Your Success Rate? Dr. X Comes to America,” Human Reprod, Vol. 11, 1996, pp. 697-699.
32. Sherins, R.J., Belker, A.M., Coulam, C.B., Opsahl, M.S., Dorfmann, A.D., Thorsell, L.P. and Schulman, J.D., “Percutaneous Nonsurgical Sperm Aspiration (NSA) from the Testis: a Highly Effective Diagnostic and Treatment Method to Achieve Pregnancy in Azoospermic Men,” American Society for Reproductive Medicine, 52nd Annual Meeting, Boston, MA, November 1996.
33. Sherins, R.J., “Male Infertility: a Total New Perspective,” Resolve (Metropolitan Washington Area, Inc.), Vol. 17, No. 5, May/June 1996.
34. Spence, W.C., Maddalena, A., Howard-Peebles, P.N. and Bick, D.P., “Contribution of the Molecular Genetics Laboratory to the Evaluation of the Persistently Hypotonic Infant,” Amer Pediatr Soc/Soc Pediatr Res, Vol. 39, No. 4, Pt. 2, 1996, p. 148A.
35. Spence, W.C., Black, S.H., Fallon, L., Maddalena, A., Cummings, E., Menapace-Drew, G., Bick, D.B., Levinson, G., Schulman, J.D. and Howard-Peebles, P.N., “Molecular Fragile X Screening in Normal Population,” Amer J Med Genet, Vol. 64, 1996, pp. 181-183.
36. Stern, H.J., Maddalena, A. and Schulman, J.D., “Correspondence: Pitfalls of Genetic Testing,” New Engl J Med, Vol. 335, 1996, p. 1235.
37. Tayebi, N., Stern, H., Dymarskaia, I., Herman, J. and Sidransky, E., “55-base Pair Deletion in Certain Patients with Gaucher Disease Complicates Screening for Common Gaucher Alleles,” Amer J Med Genet, Vol. 66, 1996, pp. 316-319.
38. Harton, G.L., Tsipouras, P., Sisson, M.E., Starr, K.M., Mahoney, B.S., Fugger, E.F., Schulman, J.D., Kilpatrick, M.W., Levinson, G., and S.H. Black, “Preimplantation genetic testing for Marfan syndrome.” Molecular Human Reproduction 2(9): 713-715, 1996.

1997

1. Bick, D.P., Stanley, W.S., Stern, H.J., Berkovitz, G.D., Meyers, C.M. and Kelley, R.I., “Prenatal Diagnosis of Smith-Lemli-Opitz Syndrome (SLO) in a Sex-reversed Fetus,” Amer J Human Genet, Vol. 61, 1997, p. A147.
2. Driscoll, D.A., Black, S.H., Holowinsky, S.C., Jackson-Cook, C., Howard-Peebles, P.N., Markello, T. and Bernaducci, J.D., “Parental Origin Studies Confirm Two DiGeorge Cases in the Same Family to be De Novo,” American College of Medical Genetics (4th Annual Meeting), Ft. Lauderdale, FL, February 28-March 2 1997.
3. Ewens, A., Custodio, C.L. and Stanley, W.S., “Superimposition of Routine G-banded and FISH Chromosome Images,” Cell Vision, Vol. 4, 1997, pp. 81-83.
4. Fisch, G.S., Holden, J.J.A., Chalifoux, M., Carpenter, N.J., Howard-Peebles, P.N., Maddalena, A., Simensen, R., Tarleton, J., Borghgraef M., Steyaert, J. and Fryns, J.P., “Natural History of Cognitive and Adaptive Behavior in Young Fragile X Males and Females: a 6-year Prospective Multicenter Study,” Amer J Human Genet, Vol. 61, 1997, p. A6.
5. Hopkin, R.J., Schorry, E., Bofinger, M., Milatovich, A., Stern, H.J., Jayne, C. and Saal, H.M., “New Insights into the Phenotypes of 6q Deletions,” Amer J Med Genet, Vol. 70, 1997, pp. 377-386.
6. Howard-Peebles, P.N., “Fragile Sites and Trinucleotide Repeats,” Appl Cytogenet, Vol. 23, 1997, pp. 1-6.
7. Jones, S.L., “Diffusion of Innovation: Nurses' use of Genetics Nursing Interventions,” Medical College of Virginia, Doctoral Dissertation, 1997, Dissertation Abstracts International, TX #4-639-572.
8. Killos, L.D., Lese, C.M., Mills, P.L., Precht, K.S., Stanley, W.S. and Ledbetter, D.H., “A Satellited 17p with Telomere Deleted and No Apparent Clinical Consequence,” Amer J Human Genet, Vol. 61, 1997, p. A130.
9. Lavenstein, B., Bick, D. and Rinaldo, P., “Ethylmalonic Aciduria in Short-chain Acyl CoA Dehydrogenase Deficiency: Recognition of the Phenotype, Genetic Polymorphism and Clinical Implications,” Annals Neurol, Vol. 42, 1997, p. P118.
10. Lese, C.M., Fantes, J.A., Precht, K.S., Killos, L.D., Stanley, W.S., Hirsch, B., Ludowese, C., Kubic, N., Riethman, H.C., Flint, J. and Ledbetter, D., “Molecular Characterization of Human Telomeres: Extension of Integrated Physical Maps and Strategies for Genotype-phenotype Correlations,” Amer J Human Genet, Vol. 61, 1997, p. A131.
11. Li, M.M., Howard-Peebles, P.N., Killos, L.D. and Stanley, W.S., “Molecular Characterization of Chromosome Markers Identified at Prenatal Diagnosis and its Clinical Implications,” Amer J Human Genet, Vol. 61, 1997, p. A132.
12. Maddalena, A., Schneider, N.R. and Howard-Peebles, P.N., “Fragile X Syndrome,” in Rosenberg, R.N., Prusiner, S.B., DiMauro, S. and Barchi, R.L. (eds.), The Molecular and Genetic Basis of Neurological Disease, 2nd ed., Butterworth-Heinemann, Boston, MA, 1997, pp.81-99.
13. Opsahl, M., Krysa, L., Schoener, C., Thorsell, L., Iwaszko, M. and Dorfmann, A., “The Number of Embryos from Anonymous Oocyte Donor Cycles Directly Correlates with Pregnancy Rates,” Soc Gynecol Invest, 44th Annual Meeting, San Diego, CA, March 1997, J Soc Gynecol Invest, Vol. 4, 1997, p. 173A.
14. Opsahl, M.S., Fugger, E.F., Sherins, R.J. and Schulman, J.D., “Preservation of Reproductive Function before Therapy for Cancer: New Options Involving Sperm and Ovary Cryopreservation,” The Cancer Journal, Vol. 3, 1997, pp. 189-191.
15. Reissner, K., Tayebi, N., Almashana, S., Blitzer, M., Cowan, T.M., Hassan, M., Maddalena, A., Spence, C., Sidransky, E. and Karson, E., “Heteroallelism for a Novel Recombinant Allele and a Rare Splice Junction Mutation in the Glucocerebrosidase Locus Presenting with Hydrops Fetalis,” Amer J Human Genet, Vol. 61, 1997, p. A161.
16. Rinaldo, P., Stanley, C.A., Hsu, B.Y.L., Sanchez, L.A. and Stern, H.J., “Sudden Neonatal Death in Carnitine Transporter Deficiency,” J Pediat, Vol. 131, 1997, pp. 304-305.
17. Robinson, W.P., Barrett, I.J., Bernard, L., Telenius, A., Bernasconi, F., Wilson, R.D., Best, R.G., Howard-Peebles, P.N., Langlois, S. and Kalousek, D.K., “Meiotic Origin of Trisomy in Confined Placental Mosaicism is Correlated with Presence of Fetal Uniparental Disomy, High Levels of Trisomy in Trophoblast, and Increased Risk of Fetal Intrauterine Growth Restriction,” Amer J Human Genet, Vol. 60, 1997, pp. 917-927.
18. Schulman, J.D. and Black, S.H., “Screening for Huntington Disease and Certain other Dominantly Inherited Disorders: a Case for Preimplantation Genetic Testing,” J Med Screening, Vol. 4, 1997, pp. 58-59.
19. Spence, W.C., Maddalena, A., Demers, D.B. and Bick, D.P., “Prenatal Determination of Genotypes Kell and Cellano in At-risk Pregnancies,” J Reprod Med, Vol. 42, 1997, pp. 353-357.
20. Stanley, W.S., Burkett, S.S., Segel, B., Quiery, A., George, B., Lobel, J. and Shah, N., “Constitutional Inversion of Chromosome 7 and Hematological Cancer,” Cancer Genet Cytogenet, Vol. 96, 1997, pp. 46-49.
21. Stavropoulos, D.J., Barrett, I.J., Lomax, B.L., Bick, D., Bernasconi, F., Robinson, W.P. and Kalousek, D.K., “Association of Prenatally Diagnosed Confined Placental Mosaicism (CPM) and Fetal Gonadal Mosaicism,” Amer J Human Genet, Vol. 61, 1997, p. A163.
22. Stearns, M., Burkett, S., Hamati, H. and Stanley, W., “Childhood Renal Cell Carcinoma with Atypical Findings Including a Variant Ph Chromosome,” Amer J Human Genet, Vol. 61, 1997, p. A83.
23. Coulam, C.B., Goodman, C., Dorfmann, A. “Comparison of ultrasonographic findings in spontaneous abortions with normal and abnormal karyotypes.” Hum Reprod, Vol 12(4), 1997, pp 823-826.

1998

1. Belker, A.M., Sherins, R.J., Dennison-Lagos, L., Thorsell, L.P. and Schulman, J.D., “Percutaneous Testicular Sperm Aspiration: a Convenient and Effective Office Procedure to Retrieve Sperm for an In Vitro Fertilization with Intracytoplasmic Sperm Injection (ICSI),” J Urol, Vol. 160, 1998, pp. 2058-2062.
2. Belker, A.M., Sherins, R.J., Dennison-Lagos, L., Thorsell, L.P. and Schulman, J.D., “Percutaneous Testicular Sperm Aspiration: a Convenient and Effective Office Procedure to Retrieve Sperm for In Vitro Fertilization with Intracytoplasmic Sperm Injection,” J Urol, Vol. 160, 1998, pp. 2058-2062.
3. Bick, D., Fugger, E.F., Pool, S.H., Hazelrigg, W.B., Yadvish, K.N., Spence, W.C., Maddalena, A., Howard-Peebles, P.N. and Schulman, J.D., “Screening Semen Donors for Hereditary Diseases: the Fairfax Cryobank Experience,” J Reprod Med, Vol. 43, 1998, pp. 423-428.
4. Fugger, E.F., Black, S.H., Keyvanfar, K. and Schulman, J.D., Births of Normal Daughters After MicroSort Sperm Separation and Medical Insemination, IVF, or ICSI,” Hum Reprod, Vol. 13, No. 9, 1998, pp. 2367-2370.
5. Jones, S.L. and Krysa, L.W., “Comfort Care Interventions in Preimplantation Genetic Testing Program,” Holistic Nursing Pract, Vol. 12, 1998, pp. 20-29.
6. Joseph, N., Bick, D., Howard-Peebles, P.N., Overhauser, J., Marinescu, R. C. and Li, M.M., “Molecular Characterization of a Patient with Oculo-auriculo-vertebral Spectrum,” Amer J Human Genet, Vol. 63, 1998, p. A139.
7. Layman, L.C., Cohen, D.P., Jin, M., Xie, J., Li, Z., Reindollar, R.H., Bolbolan, S., Bick, D.P., Sherins, R.J., Duck, L.W., Musgrove, L.C., Sellers, J.C. and Neill, J.D., “Mutations in Gonadotropin-releasing Hormone Receptor Gene Cause Hypogonadotropic Hypogonadism,” Nature Genet, Vol. 18, 1998, pp. 14-15.
8. Reissner, K., Tayebi, N., Stubblefield, B.K., Koprivica, V., Blitzer, M., Holleran, W., Cowan, T., Almashanu, S., Maddalena, A., Karson, E.M. and Sidransky, E., “Type 2 Gaucher Disease with Hydrops Fetalis in an Ashkenazi Jewish Family Resulting from a Novel Recombinant Allele and a Rare Splice Junction Mutation in the Glucocerebrosidase Locus,” Mol Gene Metabol, Vol. 63, 1998, pp. 281-288.
9. Sherins, R.J., “What Does Assisted Reproductive Technology Have to Offer my Male Infertility Patients?,” Endocrine Society, 80th Meeting, New Orleans, LA, June 1998.
10. Stavropoulos, D.J., Bick, D. and Kalousek, D.K., “Molecular Cytogenetic Detection of Confined Gonadal Mosaicism in a Conceptus with Trisomy 16 Placental Mosaicism,” Amer J Human Genet, Vol. 63, 1998, pp. 1912-1914.
11. Vidal, F., Fugger, E.F., Blanco, J., Keyvanfar, K., Catalá, V., Norton, M., Hazelrigg, W.B., Black, S.H., Levinson, G., Egozcue, J. and Schulman, J.D., “Efficiency of MicroSort Flow Cytometry for Producing Sperm Populations Enriched in X- or Y- chromosome haplotypes: a Blind Trial Assessed by Double and Triple Colour Fluorescent In Situ Hybridization,” Human Reprod, Vol. 13, 1998, pp. 308-312.

1999

1. Ackerman, J.C., Gu, W-X., Kotlar, T.J., Meeks, J.J., Sabacan, L.P., Seminara, S.B., Habiby, R.L., Hindmarsh, P.C., Bick, D.P., Sherins, R.J., Crowley Jr., W.F., Layman, L.C. and Jameson, J.L., “Mutational Analysis of DAX1 in Patients with Hypogonadotropic Hypogonadism or Pubertal Delay,” J Clin Endocrinol Metab, Vol. 84, 1999, pp. 4497-4500.
2. Alexander, P.G., Mariani, B.D. and Tuan, R.S., “Carbon Monoxide Induced Axial Skeletal Dysmorphogenesis in the Chick Embryo,” Orthopaedic Research Society, 45th Meeting, Anaheim, CA, February 1999.
3. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., Holden, J.J.A., Yang, K.T., Lee, C., Hudson, R., Gorwill, H., Nolin, S.L., Glicksman, A., Jenkins, E.C., Brown, W.T., Howard-Peebles, P.N., Becchi, C., Cummings, E., Fallon, L., Seitz, S., Black, S.H., Vianna-Morgante, A.M., Costa, S.S., Otto, P.A., Mingroni-Netto, R.C., Murray, A., Webb, J., MacSwinney, F., Dennis, N., Jacobs, P.A., Syrrou, M., Georgiou, I., Patsalis, P.C., Giovannucci Uzielli, M.L., Guarducci, S., Lapi, E., Cecconi, A., Ricci, R., Ricotti, G., Biondi, C., Scarselli, B. and Vieri, F., “Fragile X Premutation is a Significant Risk Factor for Premature Ovarian Failure: the International Collaborative POF in Fragile X Study--Preliminary Data,” Amer J Med Genet, Vol. 83, 1999, pp. 322-325.
4. Bick, D.B., McCorkle, D., Stanley, W.S., Stern, H.J., Staszak, P., Berkovitz, G.D., Meyers, C.M. and Kelley, R.I., “Short Communication: Prenatal Diagnosis of Smith-Lemli-Opitz Syndrome in a Pregnancy with Low Maternal Serum Oestriol and a Sex-reversed Fetus,” Prenat Diagn, Vol. 19, 1999, pp. 68-71.
5. Driggers, R.W., Macri, C.J., Greenwald, J., Carpenter, D., Avallone, J., Howard-Peebles, P.N. and Levin, S.W., “Isolated Bilateral Anophthalmia in a Girl with an Apparently Balanced De Novo Ttranslocation: 46,XX,t(3;11)(q27;p11.2),” Amer J Med Genet, Vol. 87, 1999, pp. 201-202.
6. Enriquez, M., Xie, J., Bick, D.P., Sherins, R.J. and Layman, L.C., “Gonadotropin-alpha Subunit Gene Mutation Analysis in Patients with Idiopathic Hypogonadotropic Hypogonadism,” Soc Gynecol Invest, 46th Annual Meeting, Atlanta, GA, March 1999, J Soc Gynecol Invest, Vol. 6, 1999, p. 52A.
7. Enriquez, M., Xie, J., Ozata, M., Bick, D.P., Sherins, R.J., Bolu, E., Ozdemir and Layman, L.C., “Pedigree Analysis of Families with Idiopathic Hypogonadotropic Hypogonadism,” Endocrine Society, Vol. P2, No. 157, 1999, p. 314.
8. Fallon, L., Harton, G.L., Sisson, M.E., Rodriguez, E., Field, L.K., Fugger, E.F., Geltinger, M., Sun, Y., Dorfmann, A., Schoener, C., Bick, D. and Schulman, J., “Preimplantation Genetic Diagnosis for Spinal Muscular Atrophy Type I. Neurology, Vol. 53, 1999, pp. 1087-1090.
9. Fisch, G. S., Howard-Peebles, P.N., Carpenter, N., Tarleton, J., Simensen, R. and Holden, J.J.A., “Age-related Features of Genetic Mutations Producing Cognitive Impairment: the Fragile X Mutation, NF1, and Williams Syndrome,” Amer J Human Genet, Vol. 65, 1999, p. A68.
10. Fisch, G.S., Holden, J.J.A., Carpenter, N.J., Howard-Peebles, P.N., Maddalena, A., Pandya, A. and Nance, W., “Age-related Language Characteristics of Children and Adolescents with Fragile X Syndrome,” Amer J Med Genet, Vol. 83, 1999, pp. 253-256.
11. Fisch, G.S., Carpenter, N.J., Holden, J.J.A., Simensen, R., Howard-Peebles, P.N., Maddalena, A., Pandya, A. and Nance, W., “Longitudinal Assessment of Adaptive and Maladaptive Behaviors in Fragile X Males: Growth, Development and Profiles,” Amer J Med Genet, Vol. 83, 1999, pp. 257-263.
12. Fisch, G.S., Carpenter, N., Holden, J.J.A., Howard-Peebles, P.N., Maddalena, A., Borghgraef, M., Steyaert, J. and Fryns, J.P., “Longitudinal Changes in Cognitive and Adaptive Behavior in Fragile X Females: a Prospective Multicenter Analysis,” Amer J Med Genet, Vol. 83, 1999, pp. 308-312.
13. Howard-Peebles, P.N., “Fragile X: From Cytogenetics to Molecular Genetics,” in Gersen, S. and Keagle, M. (eds.), The Principles of Clinical Cytogenetics, Humana Press, Inc., Totowa, NJ, 1999, pp.425-442.
14. Layman, L.C., Gray, M.R., Layman, K.L., Xie, J., Bick, D.P. and Sherins, R.J., “Mutation Analysis of the Follicle Stimulating Hormone-beta in Patients with Idiopathic Hypogonadotropic Hypogonadism,” American Society for Reproductive Medicine, Vol. S73, pp. 0-190, 1999.
15. Opsahl, M.S., Blauer, K.L., Black, S.H., Thorsell, L. and Dorfmann, A., “Anonymous Oocyte Donors Maintain High Pregnancy Rates in Consecutive Repeated Cycles,” Soc Gynecol Invest, 46th Annual Meeting, Atlanta, GA, March 1999, J Soc Gynecol Invest, Vol. 6, 1999, p. 66A.
16. Opsahl, M.S., Blauer, K.L., Black, S.H., Thorsell, L. and Dorfmann, A., “Ovarian Response and Ovarian Reserve Testing Predict Successful Pregnancy for Women 40 and Older,” Soc Gynecol Invest, 46th Annual Meeting, Atlanta, GA, March 1999, J Soc Gynecol Invest, Vol. 6, 1999, p. 140A.
17. Punnett, H.H., Schneider, A. S., Sabor, D.W., Bardakjian, T.M., Martin, K.A., Howard-Peebles, P.N. and Rogan, P.K., “Predominance of Down Syndrome Phenotype in mos45,X,+mar(X)([18]/46,XX,+21,der(21;21)(q10;q10)[2] in Cardiac Tissues,” Amer J Human Genet, Vol. 65, 1999, p. A356.
18. Taylor, H., Block, K., Olive, D., Bick, D.P., Sherins, R.J. and Layman, L.C., “Absence of EMX2 Gene Mutations in Kallman Syndrome,” Fertil Steril, Vol. 72, 1999, pp. 910-914.

2000

1. Applegarth, D.A., Toone, J.R., Rolland, M.O., Black, S.H., Yim, D.K.C., Bemis,G., “Non-concordance of CVS and Liver Glycine Cleavage Enzyme in Three Families with Non-ketotic Hyperglycinaemia (NKH) Leading to False Negative Prenatal Diagnoses,” Prenat Diagn, Vol. 20, 2000, pp. 367-370.
2. Crawford, D.C., Schwartz, C.E., Meadows, K.L., Newman, J.L., Taft, L.F., Gunter, C., Brown, W.T., Carpenter, N.J., Howard-Peebles, P.N., Monaghan, K.G., Nolin, S.L., Reiss, A.L., Feldman, G.L., Rohlfs, E.M., Warren, S.T. and Sherman, S.L., “Survey of the Fragile X Syndrome CGG Repeat and Short-tandem-repeat and Single-nucleotide-polymorphism Haplotypes in an African American Population,” Amer J Human Genet, Vol. 66, 2000, pp. 480- 493.
3. Harton, G.L., Stern, H.J., Sisson, M.E., et al, “Non-Disclosing Preimplantation Genetic Diagnosis: A Reproductive Alternative for Families at Risk for Huntington’s Disease,” American Society of Human Genetics, Philadelphia, PA, 2000.
4. Li, M.M., Howard-Peebles, P.N., Killos, L.D., Fallon, L., Listgarten, E. and Stanley, W.S., “Characterization and Clinical Implications of Marker Chromosomes Identified at Prenatal Diagnosis,” Prenat Diagn, Vol. 20, 2000, pp. 138-143.
5. Lincoln, S.R., Opsahl, M.S., Blauer, K.L., Black, S.H. and Schulman, J.D., “Aggressive Outpatient Treatment of Ovarian Hyperstimulation Syndrome with Ascites using Transvaginal Culdocentesis and Intravenous Albumin Minimizes Hospitalization,” American Society for Reproductive Medicine, 56th Annual Meeting, San Diego, CA, October 2000.
6. Opsahl, M.S., Geltinger, M.E., Black, S.H., Blauer, K.L., Lincoln, S.R., Schulman, J.D. and Fugger, E.F., “High-order Multiple Gestations can be Limited by Controlling the Number of Completely Intact Embryos Transferred in Frozen-thawed Embryo Transfer (FET) Cycles,” American Society for Reproductive Medicine, 56th Annual Meeting, San Diego, CA, October 2000.
7. Opsahl, M.S., Geltinger, M.E., Black, S.H., Blauer, K.L., Lincoln, S.R., Schulman, J.D. and Fugger, E.F., “The Number and Quality of Surviving (100%-intact and 50-99%-intact) Embryos Transferred Determines the Probability of Delivery after Frozen-thawed Embryo Transfer (FET) in 1380 Cycles,” American Society for Reproductive Medicine, 56th Annual Meeting, San Diego, CA, October 2000.
8. Penaherrera, M.S., Barrett, I.J., Brown, C.J., Langlois, S., Yong, S.L., Lewis, S., Bruyere, H., Howard-Peebles, P.N., Kalousek, D.K., Robinson, W. P., “An Association Between Skewed X-Chromosome Inactivation and Abnormal Outcome in Mosaic Trisomy 16 Confined Predominantly to the Placenta,” Clin Genet, Vol. 58, 2000, pp. 436-446, Munksgaard, 2000.
9. Stern, H.J., Harton, G.L., Sisson, M.E., Jones, S.L., Fallon, L.A., Thorsell, L.P., Getlinger, M.E., Black, S.H. and Schulman, J.D., “Non-disclosing Preimplantation Genetic Diagnosis for Huntington Disease,” Amer J Human Genet, Vol. 67, 2000, p. 42.
10. Goodwin, L.O., Karabinus, D.S., Pergolizzi, R.G. “Presence of N-cadherin transcripts in mature spermatozoa.” Mol Hum Reprod, Vol 6(6), 2000, pp 487-497.
11. Hearns-Stokes RM, Miller BT, Scott L, Creuss D, Chakraborty PK, Segars JH. “Pregnancy rates after embryo transfer depend on the provider at embryo transfer.” Fertil Steril. 2000 Jul;74(1):80-6.
12. Papageorgiou T, Hearns-Stokes R, Peppas D, Segars JH. “Clitoroplasty with preservation of neurovascular pedicles.” Obstet Gynecol. 2000 Nov;96(5 Pt 2):821-3.

2001

1. Bick, D.P., Harton, G.L., Stern, H.J., et al, “Flow-Cytometric Separation in
Preimplantation Genetic Diagnosis (PGD) of X-Linked Disease,” International Congress on Human Genetics, Vienna, Austria, 2001.
2. Maddalena, A., Richards, C.S., McGinniss, M.J., Brothman, A., Desnick, R.J., Grier, R.E., Hirsch, B., Jacky, P., McDowell, G.A., Popovich, B., Watson, M., Wolff, D.J., “Technical Standards and Guidelines for Fragile X: The First of a Series of Disease-Specific Supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics,” American College of Medical Genetics, Vol. 3, No. 3, May/June 2001.
3. Mariani, B.D., Rodriguez, E., Carver, S., Stern, D., Bick, D., Robbins, S., Tribble, L., and Litman, F., “CMV Trasmission in the NICU Via Breast Milk,” American Society of Microbiology, May 2001.
6. Myers, G.F., Mazzocco, M.M., Maddalena, A., Reiss, A.L., “No Widespread Psychological Effect of the Fragile X Premutation in Childhood: Evidence from a Preliminary Controlled Study,” J Dev Behav Pediatr, Vol. 22, No. 6, December 2001, pp. 353-359.
7. Opsahl, M.S., Blauer, K.L., Black, S.H., Dorfmann, A., Sherins, R.J. and Schulman, J.D., “Pregnancy Rates in Sequential In Vitro Fertilization Cycles by Oocyte Donors,” Obstet Gynecol, Vol. 97, 2001, pp. 201-204.
8. Spence, W.C., Kelly, C.M., and Maddalena, A., “A Highly Sensitive Fluorescence-Based Maternal Cell Contamination Test,” Am J Hum Genet, Vol. 69, No. 4, 2001, p. 444.
9. Stern, H.J., Harton, G.L., Blauer, K.L., et al, “Use of MicroSort Flow-Cytometric Sperm Separation in Preimplantation Genetic Diagnosis,” European Society of Human Reproduction and Embryology, Lausanne, Switzerland, 2001.
10. Toudjarska, I., Kilpatrick, M.W., Lembessis, P., Carra, S., Harton, G.L., Sisson, M.E., Black, S.H., Stern, H.J., Gelman-Kohan, Z., Shohat, M. and Tsipouras, P., “Novel Approach to the Molecular Diagnosis of Marfan Syndrome: Application to Sporadic Cases and in Prenatal Diagnosis,” Amer J Med Genet, Vol. 99, 2001, pp. 294-302.
11. Ungaro, P., Christian, S.L., Fantes, J.A., Mutirangura, A., Black, S., Reynolds, J., Malcolm, S., Dobyns, W.B. and Ledbetter, D.H., “Molecular Characterization of Four Cases of Intrachromosomal Triplication of Chromosome 15q11-q14,” J Med Genet, Vol. 38, 2001, pp. 26-34.
12. Blauer, K.L., Keyvanfar, K., Matken, R., Black, S.H., Wiley, S. and Fugger, E.F., IUI Pregnancy Rates Using <400,000 Total Motile Sperm in Presumed Fertile Couples Participating in the MicroSort® Sperm Separation Clinical Trial for Preconception Gender Selection,” American Society of Reproductive Medicine, Meeting Abstracts, Orlando, Florida, October 2001, Fertility and Sterility, Vol. 76, No. 3S, September 2001, p. S14.
13. Fugger, E.F., Keyvanfar, K., Matken, R., Harton, G.L., Stern, H.J. and Blauer, K.L., “MicroSort® Separation of X- and Y-Chromosome Bearing Sperm: Ongoing Clinical Trial Results After Intrauterine Insemination (IUI), In-Vitro Fertilization (IVF), and Intracytoplasmic Sperm Injection (ICSI),” American Society of Reproductive Medicine, Meeting Abstracts, Orlando, Florida, October 2001, Fertility and Sterility, Vol. 76, No. 3S, September 2001, p. S76.
14. Keyvanfar, K., Defanbaugh, D.A., Blauer K.L. and Fugger, E.F., “The Ratio of X- and Y-Bearing Sperm Cells in Discordant Offspring Gender Families,” American Society of Reproductive Medicine, Meeting Abstracts, Orlando, Florida, October 2001, Fertility and Sterility, Vol. 76, No. 3S, September 2001, p. S204.
15. Stern, H.J., Harton, G.L., Blauer, K.L., Haughs, K.N., Fallon, L.A., Fugger, E.F., Keyvanfar, K., Thorsell, L.P., Bick, D.P. and Schulman, J.D., “Use of MicroSort Flow-Cytometric Sperm Separation in Preimplantation Genetic Diagnosis,” European Society of Human Reproduction and Embryology, Annual Meeting, 2001.
16. Hearns-Stokes RM, Santoro NF, Simon JA. “Surgically induced endometriosis attenuates accrual of bone mineral density in growing rats.” Am J Obstet Gynecol. 2001 Feb;184(3):331-5.

2002

1. Black, S.H., Bergman, L.L., Opsahl, M.S., Lincoln, S.R., Blauer, K.L., “Viagra® did not Normalize Controlled Endometrial Development (CED) in Poor Prognosis Patients in a Randomized Placebo-controlled Cross-over Trial,” American Society of Reproductive Medicine, 58th Annual Meeting, Seattle, WA, October 2002.
2. Black, S., Stern, H.G., Harton, G.L., Deresh, D., Opanga, C., Blauer, K.L., “MicroSort® Separation of X-chromosome Bearing Sperm for Prevention of Genetic Disease: Ongoing Clinical Trial Results,” European Society of Human Reproduction and Embryology, Annual Meeting, July 2002, Human Reproduction, Vol. 17, p. 127.
3. Blauer, K., Deresh, D., Opanga, C., Williams, C., “Increase in Percentage of X-sort IUI Pregnancies using the Sperm Density Gradient ISolate with Microsort Sperm Separation,” World Congress of Human Reproduction, 11th annual meeting abstracts, Montreal, Canada, June 2002.
4. Juenger, C. and Stanley, W.S., “Sensitivity of Detection of B-cell Lymphoma in Bone Marrow by Fluorescence In Situ Hybridization,” Cancer Genet and Cytogenet, Vol. 138, 2002, pp.174-176.
5. Karabinus, D., Opanga, C., Deresh, D., Wiley, S., and Blauer, K., “Fertilization Rates and Purity After MicroSortâ Separation of Fresh- or Frozen-Thawed Human Sperm,” American Society of Reproductive Medicine, Meeting Abstracts, Seattle, Washington, October 2002, Fertility and Sterility, Vol. 76, No. 3S, September 2002, pp. 0-154.
6. Krysa, L.W., Thorsell, L.P., Iwaszko, M., Palmer, M., Opsahl, M.S., Blauer, K.L., “Metaphase II Oocyte Recovery Using Subcutaneous Ovidrel® Versus Subcutaneous HCG,” American Society for Reproductive Medicine, 58th Annual Meeting, Seattle, WA, October 2002.
7. Lincoln, S.R., Opsahl, M.S., Blauer, K.L., Black, S.H., Schulman, J.D., “Aggressive Outpatient Treatment of Ovarian Hyperstimulation Syndrome with Ascites using Transvaginal Culdocentesis and Intravenous Albumin Minimizes Hospitalization,” J Assist Reprod Genet, Vol. 19, No. 4, April 2002, pp. 159-63.
8. Richards, C.S., Bradley, L.A., Amos, J., Allitto, B., Grody, W.W., Maddalena, A., McGinnis, M.J., Prior, T.W., Popovich, B.W. and Watson, M.S., “Standards and Guidelines for CFTR Mutation Testing,” Genetics in Medicine, Vol. 4, 2002, pp. 379-391.
9. Stern, H.J., Harton, G.L., Sisson, M.E., Jones, S.L., Fallon, L.A., Thorsell, L.P.,
Getlinger, M. E., Black, S. H., Schulman, J. D., “Non-disclosing Preimplantation Genetic Diagnosis for Huntington Disease,” Prenat Diagn, Vol. 22, 2002, pp. 503-507.
10. Stern, H., Wiley, S., Matken, R., Karabinus, D., and Blauer, K., MicroSortâ Babies: 1994-2002 Preliminary Postnatal Follow-up Results,” American Society of Reproductive Medicine, Meeting Abstracts, Seattle, Washington, October 2002, Fertility and Sterility, Vol. 76, No. 3S, September 2002, p. 54.

 

2003

1. Blauer, K., et al “MicroSort IUI Pregnancy Rates with Very Low Sperm Numbers” European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting, Madrid, Spain, July 2003
2. Fehrenbach, L.M., Meltzer, B.W., Hager, A.M. and Mariani, B.D., “Distinguishing Enterovirus from Herpes Simplex Virus Type 1 & 2 Infection in Clinical Specimens Using a Rapid, Single-tube, 4-color, Real-time RT-PCR Assay,” American Society of Microbiology, Annual Meeting, Washington D.C., May 2003.
3. Karabinus, D., Opanga, C., Deresh, D., Matken, R., Cole, M., Wiley, S., and Blauer, K., “Semen Characteristics Do Not Predict XSort® or YSort® Purity after MicroSort® Separation of Fresh Human Sperm for IUI,” American Society of Andrology, Meeting Abstracts, Phoenix, Arizona, April 2003.
4. Matken, R., Karabinus, D., Harton, G.L., Stern, H.J., Wiley, S., and Blauer, K.L., “MicroSort® Separation of X- and Y-chromosome Bearing Sperm: Ongoing Clinical Trial Results,” American College of Obstetricians and Gynecologist, Meeting Abstracts, New Orleans, Louisiana, April 2003.
5. Opanga, C., Deresh, D., Matken, R., Wiley, S., Blauer, L., Stern, H., Karabinus, D., “Effects of Male Partner Age on Quality and Purity of Sperm After MicroSort® Sperm Separation,” Pacific Coast Reproductive Society, Meeting Abstracts, Rancho Mirage, California, April 2003.
6. Stern, H, Karabinus, D., Wiley, S., Deresh D., Matken, R., Blauer, K., “MicroSort® Babies 1994-2003: Preliminary Postnatal Follow-up Results” American Society of Reproductive Medicine Annual Meeting, San Antonio TX, October 2003

7. Alvero R, Hearns-Stokes RM, Catherino WH, Leondires MP, Segars JH. “The presence of blood in the transfer catheter negatively influences outcome at embryo transfer.” Hum Reprod. 2003 Sep;18(9):1848-52.

8. Mariani, B.D., “Advancing neonatal infectious disease diagnostics with molecular methods.” International Association of Pediatric Laboratory Medicine, Volume 4, Issue #9, Fall 2003.

9. Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, Hearns-Stokes R, Heo S, Merino M, Nieman LK. “Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis.” Fertil Steril. 2003 May;79(5):1078-85.

 

2004

1. Mariani, B.D. “Differentiating Herpes Simplex Virus from Enterovirus Infection in the Newborn using Real-time PCR.” The 20th Annual Clinical Virology Symposium, April 2004.

2. Meltzer, B.W., Fehrenbach, L.M., Mariani, B.D. “Rapid Detection of Enterovirus and HSV from a Single Patient Specimen: Implications for Improving Health Care and Patient Management. Use of Pre-formulated” ASR Beads for Real-time Infection Diagnosis.” American Association of Clinical Chemistry: Implications of Molecular Diagnostics in Health Care. November 2004.

 

2005

1. Mariani, B.D., Meltzer, B.W., and Craft, M.A. “Evaluation of Preformulated ASR ‘Beads’ for Rapid and Comprehensive Detection of Enterovirus in Clinical Samples Using the Smart Cycler.” The 21st Annual Clinical Virology Symposium, May 2005.

2. Schulman, J.D. and Karabinus, D.S. “Scientific aspects of preconception gender selection.” Reprod Biomed Online, March 2005, Vol. 10 Suppl 1, pp 125-128.

3. Thornhill, A.R., deDie-Smulders, C.E., Geraedts, J.P., Harper, J.C., Harton, G.L., Lavery, S.A., Moutou, C., Robinson, M.D., Schmutzler, A.G., Scriven, P.N., Sermon, K.D., and L. Wilton. ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. Human Reproduction Jan;20(1):35-48, 2005.

 

2006

1. Harper, J.C., Boelaert, K., Geraedts, J., Harton, G., Kearns, W.G., Moutou, C., Muntjewerff, N., Repping, S., SenGupta, S., Scriven, P.N., Traeger-Synodinos, J., Vesela, K., Wilton, L., and K.D. Sermon, ESHRE PGD Consortium data collection V: Cycles from January to December 2002 with pregnancy follow-up to October 2003. Human Reproduction 21(1): 3-21, 2006.

2. Hearns-Stokes R, Mayers C, Zahn C, Cruess D, Gustafsson JA, Segars J, Nieman L. “Expression of the proto-oncoprotein breast cancer nuclear receptor auxiliary factor (Brx) is altered in eutopic endometrium of women with endometriosis.” Fertil Steril. 2006 Jan;85(1):63-70.

3. Repping, S., Geraedts, J., Scriven, P., Harton, G., Veselá, K., Kearns, W., Viville, S., Sermon, K., Central Data Collection on PGD and Screening. Reproductive Biomedicine Online 12(3):389, 2006.